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Sumário
A cicatrização de feridas é um processo complexo delineado pelas seguintes
fases: homeostase/coagulação, inflamação, migração-proliferação e remodelação. As
células da pele são fundamentais no decorrer deste processo, nomeadamente as células
de Langerhans (LCs), os mastócitos (MCs), os macrófagos, os queratinócitos, as células
endoteliais e os fibroblastos (FBs). Esta dissertação baseou-se no estudo das células LCs
e FBs, através do uso da linha celular dendrítica proveniente da pele de fetos de ratinhos
(FSDC) e da linha celular de FBs proveniente de recém-nascidos humanos (BJ), em
condições normais e inflamatórias in vitro (estimulação através de um lipopolisacarídeo
– LPS), num ambiente hiperglicémico (30 mM de glucose).
A activação de terminais nervosos sensoriais da pele é igualmente importante
para a cicatrização, induzindo a expressão e libertação de neuropeptídeos na pele que se
ligam a receptores acoplados a proteínas G das células da pele, modulando a activação
de diferentes vias de sinalização. Na presente dissertação é estudado o efeito da
neurotensina (NT) na activação das vias de sinalização Akt, cinases de proteínas
activada por agentes mitogénicos (MAPK), nomeadamente JNK, p38 e ERK MAPKs, e
na activação do factor de transcrição NF-B. O efeito da NT na viabilidade e migração
celular, na produção de óxido nítrico (NO), na síntese de citocinas/quimiocinas pro/anti-
inflamatórias e na expressão de factores de crescimento, também foram avaliadas.
Os resultados evidenciaram que os efeitos da NT dependem da sua
concentração, do tipo e quantidade de receptores a que se ligam e a célula em que induz
efeito. Assim, enquanto 100 nM de NT induziu efeitos pro-inflamatórios, 10 nM de NT
induziu efeitos anti-inflamatórios nas células FSDCs; nas células BJ, a NT induziu
efeitos anti-inflamatórios de um modo dependente da dose utilizada. A prévia descrição
dos efeitos da NT nas células, também abrange condições de inflamação in vitro, nas
xviii
quais se observou um aumento da síntese da NT nas células FSDCs, não observado nas
células BJ, e um aumento da expressão dos receptores de NT nas células BJ, em
oposição à sua diminuição nas FSDCs. Por conseguinte, estes resultados evidenciam o
papel modelador da NT na inflamação, em que a NT pode ser produzida nas LCs e
actuar de um modo parácrino em células da pele, como os FBs.
O tratamento das células FSDCs com 10 nM de NT diminuiu a activação das
vias inflamatórias NF-B e JNK, a produção de NO, a expressão das citocinas IL-6,
TNF-α e IL-10 e o factor de crescimento vascular endotelial (VEGF), assim como
activou a via de sobrevivência ERK e aumentou a síntese do factor de crescimento
epidermal (EGF). Por outro lado, 100 nM de NT promoveram efeitos opostos. O
tratamento das células BJ com 10 ou 100 nM de NT diminuiu a expressão das
quimiocinas CCL4, CCL5, CCL11 e IL-8, assim como diminuiu a expressão das
citocinas IL-1β e IL-6, de um modo dependente da dose utilizada. NT também induziu a
expressão de EGF e promoveu a migração das células BJ.
Reduzidas doses de NT modulam negativamente a capacidade imune das células
FSDC e BJ, contrastando com o efeito pro-inflamatório de outros neuropeptídeos, como
SP e CGRP. O aumento da expressão de EGF, adicionado à diminuição da capacidade
imune das células, é importante na inibição da fase inflamatória da cicatrização, e
consequente progresso para as fases de migração-proliferação e remodelação. Pelo
contrário, altas doses de NT podem promover efeitos patológicos nas células FSDC
(estado pro-inflamatório), limitando a progressão da cicatrização. Estes resultados
perspectivam o aparecimento de novas terapias para o tratamento da ferida diabética,
caracterizada por neuropatia e pro-inflamação, podendo mesmo terminar em úlceras
incuráveis nos pés diabéticos (DFUs), com consequente amputação.
Palavras-Chave: Úlcera do pé diabético, neuropeptídeos, neurotensina, cicatrização de
feridas, células da pele, inflamação e vias de sinalização.
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Abstract
Wound healing (WH) is a complex process which involves
homeostasis/coagulation, inflammation, migration-proliferation and remodeling. Skin
cells like Langerhans cells (LCs), mast cells (MCs), macrophages, keratinocytes,
endothelial cells and fibroblasts (FBs) are fundamental to all stages of WH. In the
present work, LCs and FBs were studied using a fetal skin dendritic cell line (FSDC)
and a cell line obtained from normal newborn human foreskin fibroblasts (BJ), in
homeostatic and in vitro inflammatory conditions, stimulated by lipopolysaccharide
(LPS), and under a hyperglycemic (30 mM of glucose) environment.
The activation of sensory nerve endings of the skin is also important in WH,
inducing the expression and release of neuropeptides into the skin that bind to G-protein
coupled receptors in skin cells and modulate the activation of different signaling
pathways. This work shows the effects of the neuropeptide neurotensin (NT) in the
activation of the intracellular signaling pathways of Akt, Mitogen-activated protein
kinases (MAPK) (JNK, p38 and ERK) and the transcription factor NF-B. Moreover,
the effect of NT on cell viability and migration, nitric oxide (NO) production, synthesis
of pro- and anti-inflammatory cytokines/chemokines and expression of growth factors
was also evaluated.
The results showed that NT effects were dependent on NT concentration, on the
type and amount of receptors that bind to NT and, consequently, on the host cells.
Accordingly, while NT induced a pro (100 nM) or anti-inflammatory (10 nM) effect in
FSDCs, in BJ cells, NT only induced a dose-response anti-inflammatory effect. NT also
promoted its effects in in vitro inflammatory conditions. In addition, NT synthesis was
upregulated in FSDCs and barely synthesized in BJ cells, as well as, NT receptors were
downregulated in FSDCs and upregulated in BJ cells, in inflammatory conditions.
xx
These results enlighten that NT is an essential mediator of inflammation, produced by
LCs to act in a paracrine way in surrounding cells, like FBs.
NT (10 nM) treatment downregulated the inflammatory pathways of NF-B and
JNK, the production of NO, the expression of the acute-phase proteins IL-6 and TNF-α,
the anti-inflammatory cytokine IL-10 and the vascular endothelial growth factor
(VEGF), while the survival pathway ERK and the epidermal growth factor (EGF) were
upregulated in FSDCs. However, NT (100 nM) upregulated NO production and the
expression of acute-phase proteins, while downregulated the expression of EGF.
BJ cells treated with NT (10 or 100 nM) also downregulated the expression of
pro-inflammatory chemokines, namely CCL4, CCL5, CCL11 and IL-8, as well as, the
expression of pro-inflammatory cytokines, like IL-1β and IL-6, in a dose-dependent
way. NT also induced the expression of EGF and promoted the migration of BJ cells.
Low doses of NT negatively modulated the immune capacity of FSDCs and BJ
cells, in contrast to other neuropeptides effects, like SP and CGRP that induce a pro-
inflammatory status. In addition to this negative immunomodulation, the expression of
EGF increases, important in the downregulation of the inflammatory phase of WH and
promotion of the migration-proliferation and remodeling phases of WH. In contrast,
high doses of NT may promote pathological effects in FSDCs (pro-inflammatory state),
limiting the promotion of WH. These results may give new perspectives in the design of
new therapies for diabetic wound healing, a disease characterized by neuropathy and a
pro-inflammatory environment that can culminate into incurable diabetic foot
ulcerations (DFUs) or even foot amputation.
Keywords: Diabetic foot ulcers, neuropeptides, neurotensin, wound healing, skin cells,
inflammation and signaling pathways.
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1. Anatomy and histology of the skin
The skin has a complex anatomy consisting of diverse cells and other
components. Blood vessels are responsible for the supply of nutrients to the cell. Hair
follicles help to regulate the skin temperature, absorb harmful radiation, prevent
external agents to enter the skin and, in addition to sweat glands, promote a large
surface area for sweat evaporation. Sweat glands can be divided in eccrine and apocrine
glands. Ducts of eccrine glands pass through the dermis and epidermis and reach
directly into the skin, producing sweat (water and salts) responsible for the regulation of
body temperature and for the release of toxins from the body. Apocrine glands are
formed from the same structure as the hair follicle and sebaceous glands and are
responsible for the production of individual sexual odor. Sebaceous glands produce an
oily secretion, called sebum that is secreted through the sebaceous duct into the hair
follicle. These glands consist of lactic and fatty acids that are responsible to maintain
the acidic pH (between 3 and 5) of the skin, which inhibits the growth of most
microorganisms. Sensory and anatomic fibers make the connection between the Central
Nervous System (CNS) and the Peripheral Nervous System (PNS), including the skin.
Figure 1 - Skin anatomy (Dinh T. & A. Veves, 2006).
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The skin is divided in three main parts: epidermis, dermis and hypodermis
(Figure 1). The epidermis is essentially occupied by keratinocytes (KCs) and
Langerhans cells, the dendritic cells (DCs) of the epidermis. A lesser amount of
melanocytes, LCs and Merkel cells are also part of the epidermis. Fibroblasts,
macrophages (MΦs), mast cells and lymphocytes are dermis resident cells. Hypodermis
is constituted mainly by adipocytes cells (Prost-Squarcioni C., 2006).
Due to an external agent or trauma, skin may activate inflammation. In this
situation, monocytes, basophils, neutrophils, eosinophils, MCs, T and B lymphocytes
and epidermal LCs become activated and may be recruited to the site of injury to
mediate a proper inflammatory response. Indeed, these inflammatory cells play a major
role in the skin, as they are more than anatomically required; they are a dynamic part of
the skin.
2. Skin inflammation
Innate immunity provides the first and rapid line of defense against non-specific
infections, such as pathogenic microorganisms or its components. The innate immune
response attacks the pathogens and triggers non-specific cellular (by MΦs) and
molecular response against them. Adaptive immunity is the second and slow response to
external agents. It is a highly specific response that remains active in following injuries,
by the immune system. The major agents of the adaptive immunity are lymphocytes and
antibodies. Generally, most of the microorganisms encountered by a healthy individual
are readily cleared within a few days by the defense mechanisms of the innate immune
system before the activation of the adaptive immune system (Goldsby et al., 2003).
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2.1. Innate immune system
Allergens, proteins, bacteria or UV radiation are substances that may penetrate
the skin and initiate an inflammatory response (Wollenberg et al., 2001). Nonetheless,
not only the exogenous agents can induce an inflammatory response. Endogenous
factors may activate the immune response, such as pH, cytokines, kinins, histamines
and proteases.
The human skin is the first barrier to environmental agents, preventing the entry
of microbiologic flora and the damage of internal organs by physical agents. Innate
immune system is responsible for this skin protection and acts through anatomic,
physiologic, phagocytic and inflammatory barriers.
The skin anatomic barrier, besides hair follicles, sebaceous and sweat glands
revised in the previous chapter, comprises a thick layer of lipids and proteins,
nominated Stratum corneum (SC) that makes a barrier against the environmental
ambient and prevents transepidermal water loss (TEWL) (Blank I.H., 1953; Winsor et
al., 1944). Desquamation and secretion of mucus triggers the elimination of
microorganisms which adhere to this layer. In addition to this anatomic barrier, a
physiologic barrier composed of hydrolytic enzymes (Elias et al., 1991), antimicrobial
peptides (AMPs) (Braff et al., 2005) and lipids (Sweeny et al., 1970), as well as,
physiological skin’s responses, such as pH, pattern recognition receptors (PRRs) like
toll-like receptors (TLRs), fight against external factors (Goldsby et al., 2003).
2.1.1. Phagocytic activity and inflammation
If the previous referred barriers are not effective against pathogens, pathogens
may start inflammation. Skin inflammation involves different mechanisms that can be
divided in four events: vasodilation, increase in capillary permeability, influx of
phagocytes and repair and regeneration of new tissue (Figure 2).
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Vasodilation occurs through enlarged capillaries, which increase the temperature
and induce tissue redness (erythema). The increased permeability of vessels facilitates
the influx of fluid and cells from the capillaries into the tissue, provoking accumulation
(exudate) and inducing tissue swelling (edema). The phagocytes enter into the tissue
and kill the microbe, by releasing lytic enzymes. The digested material and the fluid of
enzymes are nominated pus. After this initial process that culminates with
inflammation, the tissue is repaired and regenerated.
Figure 2 - Cellular and molecular events triggered during skin
inflammation. Explained in detail in the text above (Fox S.I., 2003).
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These inflammatory events involve chemical mediators that can be derived from
the microorganism, released from damaged cells in response to tissue injury, generated
by several plasma enzyme systems or products of various white blood cells. These
chemical mediators can be acute-phase proteins, like C-reactive proteins, which cause
complement-mediated lyses or complement-mediated increase in phagocytosis,
histamine, which causes vasodilation and increased permeability, and kinins (for
example: bradykinin).
When MΦs are activated they release reactive oxygen intermediates (ROIs),
nitric oxide (NO) and proteolytic enzymes, in order to kill the pathogen. In order to
augment NO levels, MΦs begin to express high levels of inducible nitric oxide synthase
(iNOS) that oxidizes L-arginine and originates L-citrulline and NO. NO has a potent
antimicrobial activity and when combined with the superoxide anion, it gives rise to
more potent antimicrobial mediators. Activated MΦs also release growth factors (GFs)
and cytokines, such as Granulocyte-macrophage colony-stimulating factor (GM-CSF),
Granulocyte colony-stimulating factor (G-CSF), Macrophage colony-stimulating factor
(M-CSF), Tumor necrosis factor (TNF)-α, Interferon (IFN)-α, Interleukin (IL)-1 and
IL-6, as well as, complement proteins and chemokines, like CCL5. These inflammatory
mediators activate other immune cells and induce the recruitment of neutrophils,
monocytes and effectors T lymphocytes to the site of injury. MΦs also produce platelet-
derived growth factor (PDGF) to stimulate the proliferation of ECs and the formation of
blood vessels (angiogenesis), as well as, FBs proliferation.
The inflammatory response is followed by the repair and regeneration process.
This phase is characterized by decreased capillary permeability and vasodilation, to
ensure the activation of enzymes for blood-clotting and activate a cascade, which results
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in the deposition of insoluble strands of fibrin and, as a result, the formation of a blood
clot (Abbas A. & A.H. Lichtman, 2004; Goldsby et al., 2003).
2.2. Adaptive immune system
The first and quicker response to microorganisms occurs by the innate immune
response, which then activates the adaptive immune system. The innate immune system
not only initiates but also determines the degree and the specific ending of the adaptive
immune response, which takes days to develop and provoke durable immunologic
memory (Hammad H. & B.N. Lambrecht, 2008). Adaptive immunity is characterized
by specificity, diversity, memory, self/nonself recognition and life-long immunologic
memory to the infectious agents. Adaptive immunity is essentially mediated by B cells,
T cytotoxic and T helper (Th) lymphocytes. These cells produce and display antigen
binding cell-surface receptors that become activated (effectors cells) upon interaction
with the antigen, mediating a final specific immune response, which leads to cytokines
secretion. The adaptive immune response also regulates the innate response, minimizing
tissues damage provoked by the innate response. Accordingly, regulatory T cells are
able to repress the innate responses in vitro and in vivo (ex: Th2 cytokine response) (Lu
et al., 2006; Ralainirina et al., 2007).
Endogenous and exogenous factors may activate KCs and LCs, leading to
cytokine release that consequently activates the immunity of LCs, dermal DCs and MCs
(resident innate immune system). These cells get mature and migrate to the draining
lymph node. When reaching lymphoid organs, these cells present the antigen to naïve
Th cells which, in turn, acquire a Th17, Treg, Tr1, Th3, Th1 or Th2 phenotype.
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2.2.1. Lymphocyte acquisition of Th1/Th2 phenotype
The activation of the Th1 or Th2 response determines the outcome of the
infection (Figure 3). Some invading pathogens stimulate the Th1 response, instead of
the Th2 response; otherwise, others pathogens may stimulate higher Th2 cytokine
differentiation than Th1. The predominant anti-inflammatory Th2 response inhibits
MΦs, inhibiting parasites death which provokes pathogenicity (Abbas A. & A.H.
Lichtman, 2004; Goldsby et al., 2003).
Th1 and Th2 cells release different cytokines that are important to regulate the
cell’s immune response, in order to elicit a pro or anti-inflammatory response,
Figure 3 – Antigen-presenting cells induce T cells maturation and
differentiation into Th1 or Th2 cells.
Tho cells express the cytokine IL-12 to induce Th1 maturation and express
the cytokine IL-4 to induce Th2 maturation. Th1 cells mediate pro-
inflammatory response by releasing IFN-δ, TNF-β, GM-CSF and IL-1; Th2
cells mediate anti-inflammatory response by releasing IL-4, IL-5, IL-6, IL-
10 and IL-13 (BD Biosciences).
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respectively. These cytokines trigger the specific Th response, as well as, inhibit the
development and activity of the opposite response, inducing a cross-regulation of Th
response. The Th1 response is mediated by the expression of pro-inflammatory
cytokines – IFN-δ, TNF-β and GM-CSF – that are responsible for the elimination of
intracellular parasites and the development of autoimmune responses. Indeed, in Th1
response, MΦs are intensely activated. This response is largely connected with the
promotion of excessive inflammation and tissue injury. The Th2 response induces the
production of specific cytokines: IL-4, IL-5, IL-13 and also IL-10. IL-4 stimulates the
production of IgE antibody, IL-5 activates eosinophils, IL-4, IL-10 and IL-13 inhibit
MΦ activation and consequently, terminate the Th1 response. The Th2 response also
supports some types of allergic reactions.
2.2.2. Leukocyte migration
After leukocyte activation, these cells must migrate to the tissue containing the
stimulus. Indeed, to make possible leukocytes departure from lymphoid organs, cells
must adhere to and pass between ECs lining the walls of blood vessels, through a
process denominated extravasation. Extravasation occurs in four phases: rolling,
activation by chemoattractant stimulus (essentially IL-8 and MIP-1β), arrest and
adhesion plus transendothelial migration. Activated leukocytes start expressing G-
protein coupled receptors (GPCR) to chemoattractant stimuli released by ECs of the
blood vessels. Indeed, when chemoattractant molecules are released, lymphocytes start
migrating into the blood vessels (transendothelial migration). Chemoattractant stimuli
include platelet-activating factor (PAF), complement split products (C5a, C3a and
C5b67) and chemokines. These chemokines belong to different classes: CXC
chemokines (or CXC ligands – CXCLs), CC chemokines, C chemokines or CX3C
chemokines (Butcher E. & L.J. Picker, 1996; Cinamon et al., 2001).
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Chemokines can be divided into inducible or ‘‘inflammatory’’ chemokines and
constitutively expressed or ‘‘homeostatic’’ chemokines. Inflammatory chemokines are
critical for attracting a diverse set of effectors leukocytes, as well as, neutrophils,
monocytes/MΦs, DCs, and NKs cells, to the inflammatory sites, playing a key role in
the innate immune response. Inflammatory chemokines typically bind to more than one
chemokine receptor, suggesting redundancy in the inflammatory chemokine network.
Homeostatic chemokine receptor/ligand pairs, mediated by CXC chemokine receptor–
CXC chemokine ligand, are important for migration of antigen-presenting cells (APC)
and lymphocytes into the lymph node, whereas other homeostatic chemokine
receptor/ligand pairs are important for a specific traffic of effectors T cells. Both actions
are critically important for an effective adaptive immune response (Rot A. & U.H.
vonAndrian, 2004).
The binding of chemoattractant molecules to GPCRs of activated leukocytes
induces the intracellular signaling pathway nuclear factor-B (NF-B) pathway that
triggers neutrophil migration through the vessel wall into the tissues and upregulates
leukocyte-specific adhesion molecules (CAMs) expression by ECs, such as E-selectin,
P-selectin and intercellular adhesion molecule (ICAM)-1. These adhesion molecules are
responsible for the binding to CAM receptors of the activated and migrating leukocytes
(Kupper T. & R.C. Fuhlbrigge, 2004).
After extravasation, antigen presenting cells (APCs) are able to present the
antigen to naive and memory T cells, inducing the recruitment of other immune cells
from the blood vessels – monocytes, basophils, neutrophils, eosinophils, MCs, T and B
lymphocytes and DCs.
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3. Wound healing (WH)
WH is a dynamic and complex process that involves several cells, including a
variety of immune cells and inflammatory mediators. WH can be divided in four
overlapping phases: homeostasis/coagulation, inflammation, migration-proliferation and
remodeling. Homeostasis lasts 2–3 h, the fibrin plug is formed and aggregated platelets
release pro-inflammatory mediators such as cytokines and GFs. Cytokines recruit
neutrophils and monocytes to the wound site activating the inflammatory phase of WH,
lasting from hours to days. The proliferation phase occurs in different cell types such as
epithelial cells, ECs and fibroblasts. After cytokine stimulation, these cells migrate to
the wound site – migration phase. Extracellular matrix (ECM) is deposited and begins
the angiogenesis and re-epithelialisation, contracting and closuring of the wound. The
remodeling phase (can last several weeks) and is characterized by ECM adjustment and
formation of scar tissue. Wound healing involves the activation of different cells,
namely KCs, FBs, ECs, LCs, MΦs, MCs and platelets, inflammatory mediators, such as
GFs, chemokines and cytokines, and it also requires complex biological and molecular
events that induce cell migration, cell proliferation and ECM deposition (Singer et al.,
1999).
4. Growth factors (GFs) in wound healing
In the skin, GFs are important mediators in the complex process of WH. These
mediators are released by the majority of the skin cells and bind to their receptors which
are essentially transmembrane tyrosine kinase receptors, involved in the activation of
different signaling pathways, such as the MAPK and the Akt, which per se activate
transcription. EGF, VEGF, fibroblast growth factor (FGF), PDGF, nerve growth factor
(NGF) and transforming growth factor-β (TGF-β) are important growth factors in the
skin. PDGF is chemotactic for migration of cells into the healing skin wound, as well
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as, it enhances the proliferation of FBs and induced fibrosis. FGFs stimulate the
proliferation of mesodermal, ectodermal and endodermal cells origin, as well as,
regulate the differentiation of their target cells. EGF promotes epidermal thickness and
cellularity, stimulated by epidermal KCs proliferation and differentiation, as well as,
enhances KCs migration. VEGF is a major regulator of vasculogenesis and
angiogenesis during WH. NGF is essential for development and survival of some
sympathetic and sensory neurons with a relevant role in the skin as they release
neuropeptides that mediate inflammation. TGF-β is important for reepithelization and
tissue formation, for the expression of integrins necessary to KCs migration, as well as,
to stimulate angiogenesis, fibroblast proliferation, myofibroblasts differentiation and
matrix deposition. Considering all these GFs functions, it is implicit that GFs are
essential for the later phases of wound healing, the proliferation and remodeling phases
(Werner et al., 2003).
5. Diabetic wound healing (DWH)
Currently, diabetes affects over 285 million adults. As a consequence, diabetic
people may develop coronary heart disease, chronic kidney disease, diabetic
ketoacidosis, diabetic retinopathy and obesity. Additionally, diabetic people can
develop wound healing difficulties, persisting in three main body areas: the eye, skin
and bones.
Diabetic keratopathy is a consequence of defective healing in corneal epithelium
injuries, which is important as a barrier against ocular infection in the eyes. Patients
with keratopathy have abnormalities in corneal re-epithelialization associated with
persistent epithelial defects, infectious corneal ulcers, decreased corneal sensitivity,
increased epithelial fragility, secondary scaring, punctuate keratopathy, edema and loss
of vision (Cisarik-Fredenburg P., 2001).
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Diabetic foot ulcer (DFU) is a painless and harmful disease that also affects
diabetic people and is characterized by delayed wound healing, consequence of
differential causes. Sensory denervation - neuropathy - is an emerging risk of the
development of DFUs. In addition to neuropathy, these patients have impaired
angiogenic response and decreased blood flow supply to the site of injury (Galiano et
al., 2004; Singer et al., 1999). Delayed wound healing can also be explained by
cytokines deregulation, inhibiting the last phase of wound healing: migration-
proliferation and remodeling (Goren et al., 2006). Accordingly, TNF-α, IL-1, IL-6 and
CCL5 are produced in large amounts by immune cells and adipocytes, in type 2 diabetic
patients (Bogdanski et al., 2007). Nevertheless, other inflammatory mediators like GFs,
specifically bFGF, PDGF and VEGF are diminished in expression or their activities are
impaired. Diabetic wounded skin also presents impaired expression of ECM proteins
and misbalance between the accumulation of ECM components and their remodeling by
matrix metalloproteinases (MMPs) (Lobmann et al., 2002).
Focusing on skin cells from DFUs, like KCs and FBs, these cells have
deregulated migration and proliferation (Loots et al., 2002). In hyperglycemia and
inflammatory conditions, leukocytes (mainly neutrophils) also have defective migration
to the wound (Goren et al., 2006; Singer et al., 1999). Neutrophils have deficient
chemotactic, phagocytic and microbicidal activities, augmenting the susceptibility and
severity of infection in diabetes (Stegenga et al., 2008). MΦs undergo morphological
transformations and decrease inflammatory mediators release, like TNF, IL-1 and
VEGF (Zykova et al., 2000). Lack of upregulation of chemokines, cytokines and GFs in
KCs and dermal ECs, in the margin of chronic DFUs, associated with the reduced influx
of immune cells, may lead to poor formation of granulation tissue and chronicity of
ulcer epithelialization (Galkowska et al., 2006).
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Considering all these deficiencies in the skin of diabetic people, an extra
disturbance, such as a physical stress, can be a potential cause of foot ulcers or even
bone healing problems, like the Charcot neuroarthropathy foot (characterized by
weakened bones that can fracture) (Singer et al., 1999), that may lead to a final foot
amputation.
6. Skin as a neuroimmunoendocrine organ
Neuropeptides circulate between the brain and peripheral organs, through the
CNS, ANS and Sensorial Nervous System (SNS). SNS includes sensory receptors that
sense internal or external, chemical or physical alterations, namely chemoreceptors,
mechanoreceptors, noniceptors, photoreceptors and thermoreceptors, as well as, afferent
sensory neurons that transmit the perceived information. Sensory neurons have the cell
body located in the dorsal root ganglia of the spinal nerve, in the spinal cord, or in the
brain and can have different conducting fibers, namely A fibers (α, β and δ) and C
fibers: A fibers are myelinated and high conducting although C fibers are unmyelianted
and slow conducting. The autonomous nervous system includes parasympathetic
ganglia (close to the target organ), efferent parasympathetic motor neurons, sympathetic
ganglia (located in the spinal cord) and efferent sympathetic motor neurons
(Roosterman et al., 2006). To understand the relevance and function of these nerves, the
pungent agent from chilli peppers – capsaicin – that results in the depletion of sensory
neuropeptides and permanent degeneration of small-diameter C-fibers by binding to the
transient receptor potential vanilloid 1 (TRPV1), as well as, it’s antagonist –
capsazepine - have been used in research (Bevan et al., 1992).
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Endogenous factors, such as pH, cytokines, kinins, histamine, proteases and
exogenous agents, like allergens, bacteria and UV radiation (Wollenberg et al., 2001)
activate sensory nerve endings. After injury, MCs release histamine (Figure 4A) which
activates sensory neurons via H1 receptors, inducing orthodromic stimulation to spinal
cord (Figure 4B) and antidromic stimulation to surrounding skin cells (Figure 4C),
triggering the release of neuropeptides (Figure 4D) (Maggi C., 1991). Orthodromic
stimulation is characterized by the transmission of stimuli through unmyelinated C or
myelinated A primary afferent nerve fibers, via dorsal root ganglia to the spinal cord
and then to specific areas of the CNS, resulting in the perception of pain, burning or
other symptom (Figure 4E). Consequently, it results in the release of neuropeptides in
the site of the skin stimuli by efferent autonomous motor neurons.
Figure 4 – Neuroimmunoendocrine organ. Read text above for detailed
information (Adapted from Roosterman et al., 2006). Legend: A- Histamine
release by MCs; B – Orthodromic stimulation of spinal cord; C – Antidromic
stimulation of skin cells; D – Neuropeptides release; E – Perception of pain,
burning or other symptom.
A
B
C
D
E
D
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Antidromic stimulation is characterized by axon reflex in the neighboring
afferent nerve fibers with a final release of neuropeptides. The analgesic morphine can
activate opioid receptors located on primary afferent sensory nerve terminals, reduce the
excitability of these neurons and suppress the antidromic release of pro-inflammatory
neuropeptides, like Substance (SP) and Neurokinin (NKA). Consequently, providing
this analgesic to ulcer patients delays wound healing (Rook et al., 2009). Finally,
neuropeptides released from cutaneous nerves act on target cells via a paracrine,
juxtacrine and endoncrine pathways, similar to cytokines.
In the last three decades, neuropeptides received further attention by the
scientific community. These molecules play an important role in wound healing, not
only in the adult stage, but also in fetal skin wound healing. In a study with fetal rats
during skin development, nerves and neuropeptides were upregulated and contributed to
the survival and regeneration of peripheral neurons and modulated an ideal wound
healing process - scarless wound healing (Antony et al., 2010). However, higher levels
of nerves and neuropeptides with reduced neutral endopeptidase (NEP) levels were
shown in human and porcine hypertrophic scar with exuberant inflammation (Scott et
al., 2007). These results reveal the importance of neuropeptides in wound heal,
particularly, their effect on skin cells and in the modulation of skin inflammation.
6.1. Neuropeptides in diabetic wound healing
6.1.1. Denervation of diabetic wounded skin
Neuropathy is a possible cause of delayed diabetic wound healing and this may
be caused by altered metabolism of glucose via the polyol pathway resulting in sorbitol
accumulation, ischemia, superoxide-induced free-radical formation and impaired axonal
transport (Apfel S.C., 1999). Diabetic skin has motor, sensory and autonomic fibers
denervation: motor neuropathy causes weakness and waste of small intrinsic muscles;
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sensory neuropathy limits the sensations of pain, pressure, temperature, and others; and
autonomic denervation causes arteriovenous shunting, leading to vasodilation in small
arteries (Dinh et al., 2004). Chronic nerve compression in addition to neuropathy, may
lead to amputation. Recent approaches in clinical surgery - neurosurgical prevention -
showed relief of pain in 88% and restoration of sensation in 79% of patients, preventing
ulceration and amputation (Dellon A.L., 2007).
Diabetic neuropathy contributes to the impairment of wound healing.
Accordingly, the work of Gibran et al. (2002) demonstrated that there were fewer
nerves in the epidermis and papillary dermis of skin from diabetic human patients and
diabetes (db/db) murine skin (Gibran et al., 2002). Ever since, db/db murine skin
became a model to study the role of nerves in cutaneous injury, as these mice developed
neuropathy and delayed healing. Additionally, diminished release of neuropeptides from
nerves may be the possible cause of impaired wound healing, as Engin et al. (1996)
demonstrated delayed wound contraction and loss of neuropeptide secretion from nerve
endings in denervated tissues.
Indeed, further studies were done to identify which neuropeptides are decreased
due to the denervation and what function they had in the skin that turned impaired.
However, some other neuropeptides may have higher release and improved function. In
the next sections, several studies will be presented, describing the state of the art about
the importance of neuropeptides in wound healing.
6.1.2. Decreased SP, CGRP, NPY and POMC peptides in DWH
SP promotes a pro-inflammatory environment, inducing vasodilation,
angiogenesis, leukocyte chemotaxis and adhesion to ECs, which ensures the
extravasation, migration and subsequent accumulation of leukocytes into the site of
injury. Some studies performed in mice show that in normal wound healing, SP release
Introduction
19
induced by stress augments the growing nerves and connection of SP to MCs, leading to
a rise in apoptotic cells in the skin (Peters et al., 2005). Additionally, SP upregulates
NO production, enhancing wound closure kinetics and epithelialization (Muangman et
al., 2009), it also increases the density of neutrophils, DCs, ECs and MΦs, and triggers
the production of TNF-α, IL-1-β, IL-2 and IL-6 by T-lymphocytes (Delgado et al.,
2003). In contrast, in skin biopsies of diabetic wounds, SP levels are reduced due to
elevated levels of the degrading enzyme NEP (Antezana et al., 2002) and reduced SP-
positive nerve fibers (Lindberger et al., 1989). Even though,  exogenous SP treatment
improves wound healing kinetics in animal models (Gibran et al., 2002).
CGRP is known to induce neurogenic inflammation, inducing a pro-
inflammatory response in different cells, including the formation of new vessels,
important during physiological and pathological wound healing (Toda et al., 2008). In
WH, inflammation may induce CGRP release, and CGRP is able to activate
inflammatory pathways (Ambalavanar et al., 2006). Diabetes decreases the expression,
release and action of CGRP, resulting in reduced CGRP-mediated vasodilation
(Sheykhzade et al., 2000).
In type 1 and type 2 diabetic patients, NPY levels are increased in the
hypothalamus, however NPY levels in the skin are reduced (Wallengren et al., 1995).
NPY binding to Y2 receptors is important in angiogenesis and this binding induces the
formation of microvessels with distinct vascular tree-like structures. As a result, the
deletion of Y2 receptor in diabetic mice results in the blockage of NPY-induced
angiogenesis and delayed WH (Ekstrand et al., 2003). These consequences might
explain a possible cause of delayed WH in diabetic patients, reinforcing the importance
of NPY in both the inflammatory and angiogenic phases of WH.
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In diabetic rats, POMC peptides, like ACTH and α-MSH, were less expressed.
However, Gohshi et al. (1998) demonstrated contradictory results in short-time (1
week) diabetic rats, detecting an increase of ACTH (POMC peptide) release, via cAMP
pathway. In long-term diabetic rats (8 weeks), the results were already concordant, since
ACTH release decreases, which may be explained by an alteration in the properties of
the L-type Ca2+ channel coupled with the CRF receptor, or with the CRF receptor itself.
Knowing the anti-inflammatory role of POMC peptides, less is known about how its
decreased levels affect wound healing.
6.1.3. Increased CRF and NT levels in diabetic wound healing
Type 2 diabetic patients have subclinical hypercortisolism. This is a
consequence of Hypothalamic-pituitary-adrenal axis hyperactivation, corticotropin-
releasing factor stimulation and pituitary adrenal peptides release. Impaired stress
response is responsible for the decrease of pituitary and adrenal sensitivity, as well as,
the glucocorticoid negative feedback sensitivity (Chan et al., 2002). Accordingly,
chronic stress delays wound healing in humans and rodents (Detillion et al., 2004). In a
study performed with a rhesus monkey model of wound healing, stress decreased IL-8
and CCL3 expression (Kalin et al., 2006), as well as, IL-1β and PDGF, in a stress model
of mouse wound healing. Thus, the authors infer that glucocorticoids release mediated
by stress is responsible for delayed wound healing.
Studies with pancreas and intestines from diabetic mice have shown elevated
levels of NT. In fact, NT may be implicated in the pathogenesis of DWH (Fernstrom et
al., 1981). However, studies concerning the involvement of NT in DWH have not been
performed yet.
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6.2. Neuropeptides in skin inflammation
Neuropeptides have appeared as key regulators of inflammation and
inflammatory processes per se, giving new insights in the understanding of the skin’s
immune system. Neuropeptides may be released in the skin by the Autonomous
Nervous System and also by skin cells, such as KCs, ECs, FBs, epidermal DCs and LCs
(Leung M. & C.C. Wong, 2000; Wang et al., 2002). Neuropeptides may induce the
activation of immune cells (neutrophils, MΦs, antigen presenting DCs and
lymphocytes). As a result, T-lymphocytes may release specific anti or pro-inflammatory
mediators (cytokines, chemokines and GFs), B cells can produce antibodies and LCs
may modulate antigen presentation (Roosterman et al., 2006). Accordingly,
inflammatory mediators are able to start and end skin inflammation and determine
important immune functions, such as proliferation/differentiation/apoptosis of skin
cells, vasodilation/vasoconstriction, vessels permeability, angiogenesis, T cells
chemotaxis to the site of injury, MC degranulation and histamine release, pro/anti-
inflammatory cytokines release and improvement of WH. Neuropeptides may regulate
cytokines release and the inflammatory response, as well as, its own function, by
inducing its degradation with cell-associated neuropeptide-degrading peptidases, like
NEP, and by controlling nerve growth (Olerud et al., 1999).
Neuropeptides predominantly interact with GPCR. These receptors exist in
different cell types in the skin, including in KCs, microvascular ECs, merkel cells, FBs
and all immune cells of the skin; and activate different signaling pathways and
mediators, namely cyclic adenosine monophosphate (cAMP), the
phosphoinositol/calcium, the diacylglicerol (DAG)/protein Kinase C (PKC), the NF-kB,
the Phosphoinositide 3-kinase (PI3-K)/Akt and also the Mitogen-activated protein
kinases (MAPK) pathways.
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6.3. Signaling pathways activated by neuropeptides
Inside the skin cells, different signaling mechanisms can be activated when a
ligand binds to its receptor. Different ligands may activate different signaling pathways,
such as pathogens, metabolites from pathogens, GFs, cytokines, neuropeptides and
other physiologic stimuli. The activation of skin cells by neuropeptides involves several
intracellular signaling cascades that are mainly initiated by a seven membrane GPCRs.
GPCRs are heptahelical hydrophobic segments which form seven-
transmembrane-spanning domains (TM7), with an extracellular N terminus and an
intracellular C terminus (Figure 5). These receptors received this name because they
associate with intracellular heterotrimeric G proteins (Gαβδ), which become activated
when an extracellular ligand binds to a GPCR. This binding induces a conformational
change in the receptor, promoting heterotrimeric G protein activation. G proteins are
divided in four families, based on the similarities functions to the α-subunit, namely Gs,
Gi, Gq and G12/13 (Oldham W. & H.E. Hamm, 2008; Wilkie et al., 1992). G-protein
downstream signaling may activate different signaling pathways and mediators, namely
cAMP, phosphoinositol/calcium, DAG/PKC, NF-B pathway, PI3-K/Akt pathway, and
MAPK pathways.
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Figure 5 - Diversity of G protein-coupled receptor signal transduction
pathways (SIGMA-ALDRICH).
The DAG/PKC/NF-B pathway also involves the Gq protein, responsible for the
generation of IP3 and DAG, by PLC. DAG activates PKC, a multifunctional kinase that
phosphorylates many different targets. Indeed, PKC may activate the NF-B pathway.
The NF-B signaling pathway can be activated through two different mechanisms, a
pathway dependent on the NF-kB inhibitor, IBα – the classical pathway of NF-B
activation – and independent on IBα – the alternative pathway of NF-B (Senftleben
et al., 2001). Here will be discussed the classical pathway of NF-B and innate
immunity activation (Figure 6). NF-B is activated upon IκBα phosporylation, which is
an NF-B inhibitory protein localized in the cytosol and complexed with the NF-B.
This phosphorylation leads to its ubiquitination and degradation, by proteasome.
Consequently, NF-κB is then translocated into the nucleus where it binds to specific
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Figure 6 – NF-B signaling pathway (Bonizzi G. & M. Karin, 2004).
Read text for detailed explanation.
sequences of DNA called response elements, activating transcription. NF-B is
involved in diverse cells immune responses, increasing the transcription of genes like
chemokines (IL-8, CCL5, MIP-1 and MCP-1), cytokines (IL-6, IL-1β, TNF-α, GM-
CSF, IL-4 and IL-5), adhesion molecules (VCAM-1, ICAM-1 and E-selectin), enzymes
that produce secondary inflammatory mediators (iNOS, COX-2 and PLA2) and
inhibitors of apoptosis (Ghosh et al., 1998) .
GPCR activates PI3-K either through βγ subunits associated to G-proteins or via
Receptor Tyrosine kinase (RTK) and integrin transactivation. PI3-K activates Akt
(Figure 7) that phosphorylates phosphatidylinositols of the cell membrane, generating
phosphatidylinositol (3,4,5)-trisphosphate (PIP3) from phosphatidylinositol-4,5-
bisphosphate (PIP2). At the cell membrane, PIP3 recruits the serine/threonine protein
kinase Akt, also known as protein kinase B (PKB) or RAC-PK, and phosphoinositide-
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dependent protein kinase (PDK)-1. Akt binding to PIP3 induces a conformational
change, making Akt accessible to phosphorylation by PDK-1, which culminates with
Akt activation. PKB/Akt further activates or inhibits different molecules (for example,
mTOR and NF-B) mediating different cell mechanisms, like cell growth, cell cycle,
transcription, translation, cell proliferation, apoptosis, cytoskeletal reorganization and
glycogen synthesis (Brazil et al., 2002).
Figure 7 – Akt signaling pathway, downstream activation/inhibition
molecules and final cell effects (Invitrogen). Read text for detailed
explanation.
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Mitogen-activated protein kinases are a family of serine/threonine protein
kinases involved in different cell functions, such as cell growth, development,
proliferation, differentiation and apoptosis. MAPK signaling cascades are organized
hierarchically through the action of three kinases. MAPKs are phosphorylated and
activated by MAPK-kinases (MAPKKs), which in turn are phosphorylated and
activated by MAPKK-kinases (MAPKKKs). The MAPKKKs are in turn activated by
upstream interaction with the family of small GTPases and/or other protein kinases.
The MAPK essentially involves Ras, which is a small G protein whose
activation by GTP initiates the MAPK cascade. Figure 8 shows Ras downstream
cascade of phosphorylations, which ends in the ERK1/2, c-Jun N-terminal kinases
(JNK) 1/2/3 and p38 MAPK phosphorylation and activation. These last molecules
regulate the expression of diverse genes involved in inflammation (Zhang et al., 2007).
The activation of MAPKs, the magnitude and duration of their activation, and
their inactivation are critical in mediating appropriate physiological responses. Indeed,
MAPK phosphorylation, that trigger its activation, is highly regulated by MAPK
phosphatases (MKPs) or dual specificity phosphatases (DUSPs), that function as
negative regulators, responsible for MAPK dephosphorylation (Farooq A. & M.M.
Zhou, 2004; Theodosiou et al., 2002). These phosphatases have identical structural
features: a C-terminal catalytic domain containing a highly conserved signature motif
HCXXXXXR and two Cdc25-like domains. The dephosphorylation occurs in threonine
and/or tyrosine residues within the signature sequences -Thr-X-Tyr- located in the
activation loop of MAPKs. To date, thirteen members of this family had been identified,
with different substrate affinities and distinct subcellular localizations and types of
regulation.
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Figure 8 – MAPK signaling cascades (Invitrogen). Read text for detailed
explanation.
Neuropeptides activate different signaling pathways that regulate the immune
responses, degranulation of mast cells, the synthesis/release of pro or anti-inflammatory
cytokines and chemokines, the control of vasodilation/vasoconstriction and the
proliferation/differentiation of cells. For that, neuropeptides bind to specific receptors in
different skin cells, like KCs, LCs, FBs, MΦs and MCs, and they also recruit
lymphocytes from the lymph nodes. Diverse neuropeptides mediate all these cell
responses, namely SP, Vasointestinal Polypeptide (VIP), Calcitonin gene-related
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peptide (CGRP), Pituitary adenylate cyclase activating polypeptide (PACAP),
Neuropeptide Y (NPY), Corticotropin Releasing Hormone (CRH), Proopiomelanocortin
peptides (POMC peptides), Melanocyte-stimulating hormone (MSH), Secretoneurin
(SN), Urocortin and Neurotensin (NT). This work will address the role of NT in DCs
and FBs.
6.4. Neuropeptides signaling in dendritic cells (DCs)
DCs received this name because of the long membrane extensions they possess,
that are similar to dendrites of nerve cells. There are many types of DCs: LCs,
interstitial DCs, myeloid cells and lymphoid DCs; even though, the main function of
mature DCs remains unchanged - the presentation of the antigen to the Th cells. In
inflammation, mature and immature forms of LCs and interstitial DCs capture the
antigen, by phagocytosis or endocytosis, and then migrate into draining lymph nodes,
functioning as APCs which, in turn, initiate Th cells response. DCs give important
information to T and B cells about inflammation, such as the nature of the pathologic
insult and the type of tissue in which the inflammation occurred (Goldsby et al., 2003).
Taking in consideration these essential functions of DCs, it is easy to comprehend that
impairment of these cells leads to immune diseases.
The role of neuropeptides in the regulation of DCs is well documented at
different levels, essentially in the density of LCs, DCs migration and maturation, in the
antigen-presenting function and in the inhibition/upregulation of the immune system.
Subsequently, in the next section, it will be addressed the immune regulation of DCs by
different neuropeptides.
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6.4.1. SP, CGRP, VIP, Secretin, SN and stressor neuropeptides induce
migration and maturation of LCs
Some neuropeptides play a chemotactic role in the migration and maturation of
blood-derived DCs. CGRP, VIP, Secretin and SN induce immature DC migration, while
SP stimulates its migration only slightly (Dunzendorfer et al., 2001).
SP receptors (NK-1) are present in normal murine and human DCs and can elicit
transcription factor activation in DCs (Marriott I. & K.L. Bost, 2001). Mathers et al.
(2007) used the gene gun to deliver transgenic (tg) Ag to the skin of C57BL/6 mice and
the selective NK-1R agonist. The administration of NK-1R agonist induced NF-B
mediated migration of activated LCs to skin-draining lymph nodes, increasing the
expression of tg Ag in the epidermis and stimulating LCs to induce both Th1 and Tc1
cellular responses and antibody mediated responses (Mathers et al., 2007).
Well-established murine sound stress model (frequency of 300 Hz and an
intensity of 75 dB, during 24h, at intervals of 15 sec) induces DCs maturation and
migration. Accordingly, some activation related molecules are upregulated, such as
MHC class II and CD11c, inducing cellular activation and triggering neutrophil
respiratory burst and langerin expression. Langerin is an intradermal transmembrane
cell surface antigen receptor that binds to mannose cell wall of pathogens, inducing its
internalization into LCs Birbeck granules and providing access to a nonclassical
antigen-processing pathway. Not only maturation is stimulated, but also migration, as it
can be observed by the upregulation of the adhesion molecule ICAM-1, in murine skin
(Joachim et al., 2008). Since sound stress may enhance stressor neuropeptides, like
CGRP, SP, NT, CRH and α-MSH, these can be responsible for DC maturation and
migration to blood vessels.
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6.4.2. CGRP, VIP, PACAP and α-MSH mediate anti-inflammatory and Th2
responses in LCs
Tori et al. (1998) determined the anti-inflammatory properties of CGRP, in LCs
(Tori et al., 1998). Indeed, CGRP inhibits antigen-presenting function and enhances
anti-inflammatory cytokines like IL-10. Since CGRP acts in DCs, mature and immature
DCs express type 1 CGRP receptors that regulate the interaction of LCs with T cells.
Indeed, CGRP downregulates CD86 (a cell surface ligand that provides co-stimulatory
signals essential for T cell activation and survival), HLA-DR (involved in antigen
presenting cell function to T cells) and T cell proliferation, in human DCs (Carucci et
al., 2000). In a recent study performed in murine DCs, the authors verified that CGRP
also inhibits TLR-stimulated production of inflammatory mediators, mediated by the
cAMP/PKA pathway, leading to a rapid up-regulation of the transcriptional repressor,
the inducible cAMP early repressor (ICER). Additionally, CGRP also attenuated serum
TNF-α levels (Harzenetter et al., 2007).
α-MSH also induced an anti-inflammatory function on DCs, inducing IL-10
release. In addition, PACAP and VIP suppress LC antigen presentation and modulate
cytokine production. In a LPS-induced inflammatory study, NF-B is activated in both
a LC-like cell line (XS52) and an epidermal LC. Treatment of cells with these
neuropeptides suppresses the phosphorylation of p-IKKβ and consequently inhibits the
normal activation of the NF-B pathway (Ding et al., 2007). Indeed, the Th1 response is
inhibited, while the Th2 immune response is enhanced (Ding et al., 2008).
6.5. Neuropeptides signaling in fibroblasts (FBs)
Bayreuther et al. (1988) concluded that human FBs differentiate along a terminal
lineage, in parallel with hemapoietic cells. This lineage comprises different phenotypic
FBs: resident FBs, circulating precursors and transforming epithelial cells. In addition to
Introduction
31
migrating surrounding FBs to the site of injury, resident FBs are important in rapid
proliferation after injury. Circulating precursors, also called fibrocytes, are blood borne
cells expressing the hematopoietic cell surface markers CD34+, CD45+ and collagen,
and are able to leave the blood, enter into the tissue and become a FB. These cells are
able to migrate to wounds to promote wound healing and fibrotic tissue repair (Yang et
al., 2002). Transforming epithelial cells are epithelial cells that can give rise to FBs, in a
process called epithelial-mesenchymal transition (EMT).
FBs are present in different tissues and their main function resides in ECM
production and turnover. In the skin, FBs are present in the dermis, in the papillary,
reticular dermis and dermal papilla region of the follicle (Sorrell J. & A.I. Caplan,
2004), and produce and organize the ECM, supported by FB communication with each
other and other cell types, like KCs. Moreover, FBs regulate skin immune function, as
these sentinel cells produce and release chemokines (like IL-8 and CCL5), COX and
prostanoids after activation by infectious agents (like LPS of bacteria) and  factors
emanating from infiltrating hematopoietic cells (Smith et al., 1997).
FBs are essential cells in wound healing and differentiate, migrate and increase
ECM synthesis in the proliferation and remodeling phase of WH (Takehara et al.,
2000). Skin FBs proliferation is regulated by various GFs, like PDGF, b-FGF, TGF-β
and connective tissue growth factor (CTGF). Additionally, PDGF and CTGF per se
stimulate chemotaxis of skin FBs; b-FGF stimulates angiogenesis; and TGF-β
stimulates ECM production. FBs differentiation involves a change in FBs phenotype,
from a relatively quiescent state, in which FBs are only responsible for the slow
turnover of ECM, to a proliferative and contractile phenotype termed myofibroblasts.
Myofibroblasts have prominent cortical microfilament bundles with dense bodies and
have a distinct alpha-smooth muscle actin (α-SMA) important for in vivo contraction.
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These cells are important during WH, as they can contract to promote wound closure, as
well as, induce fibrogenesis (ECM production), fundamentally fibronectin and collagen.
ECM molecules constitute the newly granulation tissue and give structure integrity to
the granulation tissue. Also, proteinases (MMPs and plasminogen activator/plasmin)
activity and consequent degradation of ECM is also important in tissue remodeling after
new ECM deposition - immature matrix is remodeled as part of scarring and scar
contraction. In the end, in physiological conditions, myofibroblastic cells die via
apoptosis forming the scar, while in pathological conditions, these cells are responsible
for fibroses, as these cells persist in the tissue and augment ECM (Jeon et al., 2007).
Neuropeptides regulate FBs proliferation and migration, as well as, modulate FB
immune function. In fact, this modulation is largely documented for SP, but poorly
explored for others neuropeptides. In the next section, it will be reviewed the current
knowledge of the neuropeptides effects on FBs.
6.5.1. SP and enkephalins enhance FBs proliferation
FBs proliferation is mediated by diverse neuropeptides, namely enkephalins and
SP. A unique study from Weisinger et al. (1995) showed that enkephalins mediate
cultured embryonic FBs proliferation, shifting FBs from their normal G1 restriction
point to one in the S-phase (Weisinger et al., 1995). Considering SP, several authors
reported FBs proliferation mediated by SP. Indeed, SP by itself and in synergy with IL-
1α and PDGF induce bone marrow (BM) FBs proliferation, in which SP, IL-1α and
PDGF-BB receptors induction is important to their synergistic effects. Moreover, as IL-
1α induces NK-1 mRNA, synergism of SP with IL-1α is favored (Rameshwar et al.,
1997). In addition, the release of IL-3 from BM-derived MCs induces FBs proliferating
activity, partially abrogated by the SP antagonists, indicating that SP or histamine
release (provoked by SP) augment the fibrogenic cytokine IL-3 and consequently, FBs
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proliferation (Katayama I. & K. Nishioka, 1997). The proliferative effect of SP was also
determined in cultured granulation tissue FBs in vitro, in a remarkable dose-dependent
fashion, and partly mediated by bFGF (Jiang et al., 2004). Accordingly, SP may induce
in vitro expression of bFGF mRNA and bFGF protein in FBs of granulation tissue,
significant in wound healing (Jiang et al., 2003). Furthermore, immunoreactive stain for
SP in granulation tissue is correlated with gene expression of EGF, FGF-2 and their
receptors (Lai et al., 2003). Moreover, in  wounds of scalded rats, SP levels are
increased and mediate proliferative and anti-apoptotic effects by elevating the
expression of proliferating cell nuclear antigen and BCL-2 in FBs, with greater
influence on keloid FBs than on hypertrophic scar FBs (Jing et al., 2010), mediating
WH and scar formation.
6.5.2. Neuropeptides induce FBs migration
SP, SN, bombesin and CGRP are involved in FBs migration, in different tissues.
In accordance, SP chemoattracts human FBs in vitro, in a concentration-dependent
migratory response mediated by the C-terminus of the neuropeptide through NK1
receptor but not NK2 (Kähler et al., 1993). SN, by the C-terminal fragment of the
peptide, also triggers the selective migration of human skin FBs in vitro, but does not
stimulate their proliferation (Kahler et al., 1996). Bombesin and CGRP induce IMR-90
FB migration, essential in repair and healing of airway injury (Yule et al., 1999).
6.5.3. Neuropeptides regulate FBs immune function
Neuropeptides are also implicated in FBs immune function. In accordance, SP
mRNA augments in response to the transforming growth factor (TGF)-β and bFGF in
rheumatoid arthritis FB-like synoviocyte and osteoarthritis FB-like synoviocyte (Inoue
et al., 2001). Higher SP levels induce proliferation and enzyme secretion in FB-like
synoviocytes present in joints. In addition, SP mediates the expression of MHC class II,
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ICAM-1, vascular cell adhesion molecule (VCAM)-1, LFA-3, CD40, B7.1 or B7.2
molecules, on rheumatoid arthritis FB-like synoviocyte incubated with IFN-γ or IL-1β
or TNF-α. As a result, SP potentiates the effect of pro-inflammatory cytokines on the
expression of VCAM-1 on rheumatoid arthritis FB-like synoviocyte (Lambert et al.
1998). Moreover, SP, but not VIP or SN, induces human neutrophil adhesion and
consequent migration in a 5-mµ pore polycarbonate filter system covered by human
lung FB monolayers, representative of subendothelial barrier of FBs and extracellular
matrix towards lung inflammatory sites, in acute lung injury (Kähler et al., 2001).
Neuropeptides are also important in inflammatory processes of angiogenesis. In fact,
SP, CGRP, VIP and NPY alter angiogenic GFs expression, namely angiogenin,
angiopoietin-2, PDGF, VEGF, EGF, bFGF, HE-EGF, hepatocyte growth factor (HGF),
leptin and placental growth factor, in in vitro pulp FBs, suggesting neuropeptides
importance in pulpal inflammation and repair (El Karim et al., 2009).
6.6. Neurotensin (NT) and neurotensin receptors (NTRs)
NT is a tridecapeptide essentially localized in the CNS and specialized endocrine
cells (N-cells) of the small bowell (Reinecke M., 1985). NT response is mediated by its
binding to one of the three existing NTRs: neurotensin receptor 1, 2 and 3 (NTR1,
NTR2 and NTR3). NTR1 and NTR2 are GPCRs and NTR3 is an intracellular receptor
with a single transmembrane domain, which is 100% homologous to gp95/sortilin.
NTR1, rather than NTR2, exhibits high affinity for NT (Chalon et al., 1996) and NT
effects are essentially mediated by this receptor, as NTR3 is predominantly localized in
the trans Golgi network although the mature protein can also be present in the plasma
membrane (Nielsen et al., 1999).
NTRs undergo molecular and cellular regulation after acute and chronic agonist
exposure. Indeed, like other GPCRs, upon agonist stimulation, the receptor is
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uncoupled, internalized, endocytosed, and the cells are completely desensitized. At the
same time, NT message is transduced and NT cellular effects occur. Accordingly, this
desensitization process is dependent on the amount of free and functional NTR1 at the
surface and this state remains until NTR1 is recycled to the membrane or new receptors
reach the cell surface, or both. Also, NTR1 responses are dependent on the time and the
dose of agonist exposure. Chronic stimulation with high agonist doses induces
permanent cell sensitivity to NT. Summarizing, the cellular response of NT is
determined by NT release, NT degradation and the dynamic regulation of NTR1
(Sorrell J. & A.I. Caplan, 2006).
NTRs mediate the activation of different signaling pathways. NTR1 induces
intracellular signaling through PLC and the inositol phosphate signaling pathway and is
also known to function through the production of cGMP, cAMP and arachidonic acid,
as well as, the MAP kinases pathways and inducing inhibition of Akt activity. NTR2
receptor internalizes receptor–ligand complexes and activates ERK1/2 but does not
induce calcium mobilization. NTR3 may be involved in the migration of human
microglial cells, via the stimulation of both MAP and PI3-K pathways (St-Gelais et al.,
2006).
6.6.1. NT in the CNS, gastrointestinal tract and skin
NT is involved in inflammatory processes occurring in different organs, by its
release through peripheral nerves or by its production in tissues. In the nervous system,
NT has a pro-inflammatory role, inducing vasodilatation, vascular permeability
increase, MCs degranulation and enhancement of directional migration and
phagocytosis of neutrophils (Goldman et al., 1983). NT also induces the expression of
several cytokines/chemokines, including IL-1 and MIP-2, in microglia cells (Dicou et
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al., 2004). This expression is mediated by a mechanism dependent on both PI3-K and
MAP kinases pathways, via NTR3 (Martin et al., 2003).
In the gastrointestinal tract, NT is involved in the physiopathology of colonic
inflammation, a tissue rich in NTR1 (Castagliuolo et al., 1999), stimulating NF-B
dependent IL-8 secretion and IL-8 gene expression in human colonocyte cells (Zhao et
al., 2003). However, in a recent research study performed in the gastrointestinal, NT
treatment induces an anti-inflammatory cytokine profile in colitis, characterized by the
diminishment of IL-6 and TNF-α (Assimakopoulos et al., 2008).
Less is known about the role of NT in skin inflammation. NT-positive fibers and
NT mRNA are present in the skin and dorsal root ganglia (Donelan et al., 2006;
Hartschuh et al., 1983). The prohormone convertase 5, an enzyme that cleaves pro-NT
into its active form, is expressed in dorsal root ganglia. Additionally, NT is also
involved in MCs histamine release and granule extrusion (Carraway et al., 1982).
Knowing the role of NT in the CNS and gastrointestinal tract inflammation, much
information is still missing considering skin inflammation. In fact, NT presence in the
skin has been implicated in the pathogenesis of skin disorders, exacerbated by stress
(Singh L., 1999).
6.6.2. The effects of NT on LCs and FBs
In accordance with the present literature, the effect of NT on LCs and FBs was
not explored until the current date. Knowing the potential effects of NT in inflammation
and the important role of neuropeptides in the regulation of these cells function, it can
be stated that this poorly explored subject is undoubtedly a prospective area of research.
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7. Objectives
This work attempts to address the role of NT in skin inflammation and its
possible functions in important processes of WH. Indeed, this thesis will be focused on
signal transduction, inflammatory mediators and pro/anti-inflammatory function of
cells, and cell migration occurring in FSDCs and BJ cells, key cells of the epidermis and
dermis, respectively. Also, these studies aim to determine if different glucose levels
alter the metabolism and transcription machinery of FSDCs or BJ cells. Finally, after
knowing the role of NT in skin inflammation, a possible connection between NT effects
in skin inflammation and WH will be determined. Additionally, it will be described the
role of NT in pathological conditions, determining its repercussions in DWH.
Understanding the role of neuropeptides in the skin, its application on skin wounds
could be a potential therapy for skin pathologies, like DFUs, a problematic and
prevalent skin disease that can lead to a final amputation.
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1. Reagents
Lipopolysaccharide (LPS) from Escherichia coli (serotype 026:B6) was obtained
from Sigma Chemical Co. (St. Louis, MO, USA), NT was obtained from Bachem (Weil
am Rhein, Germany) and NTR1 inhibitor SR48692 was obtained from Axon Medchem
(Groningen, The Netherland). The protease inhibitor cocktail (Complete Mini) and the
phosphatase inhibitor cocktail (PhosSTOP) were obtained from Roche (Carnaxide,
Portugal). Bicinchoninic acid (BCA) kit assay was obtained from Novagen. 30%
Acrylamide/BisSolution 29:1 (3.3% c), TEMED and SYBR green were obtained from
BioRAD, High Capacity cDNA Reverve Transcription kit was obtained from Applied
Byosistems.
The polyvinylidene difluoride (PVDF) membranes and the antibody against β-
actin were purchased from Millipore Corporation (Bedford, MA). The antibodies
against pAkt (Thr 308) and NTR were purchased from Santa Cruz (Frilabo), the
antibodies  against total JNK was obtained from UpState (Tape Group), the antibodies
against phopho-(p-)JNK, p-ERK, p-p38 MAPK and total Akt were purchased from Cell
Signaling and the antibody against total p38 MAPK was purchased from Biolegend
(Tape Group). The alkaline phosphatase-linked secondary antibodies (anti-mouse and
anti-rabbit) and the enhanced chemifluorescence (ECF) reagent were obtained from GE
Healthcare (Carnaxide, Portugal). The Vectashield mounting medium was purchased
from Vector, Inc. (Burlingame, CA, USA) and the Alexa Fluor 555 phalloidin antibody
was purchased from Invitrogen (Barcelona, Spain).
TRIzol® was obtained from Invitrogen, diethyl pyrocarbonate (DEPC) was
acquired from AppliChem. Methanol, ethanol, isopropanol were obtained from Merck.
All primers were obtained from MWG Biotech (Ebersberg, Germany). All other
reagents were purchased from Sigma Chemical Co.
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2. Cell culture
The fetal mouse skin-derived dendritic cell (FSDC) line was kindly supplied by
Dr. G. Girolomoni (Department of Biomedical and Surgical Science, Section of
Dermatology and Venereology, University of Verona, Italy). This cell line is a skin DC
precursor with antigen presenting capacity. This cell line was previously characterized
and had a surface phenotype consistent with a LC progenitor (H-2d.b+, I-Ad.b+, CD54+,
CD11b+, CD11c+, MHCII+, MHCI+, B7.2+, B7.1-, CD44+, B220-, CD3-) (Girolomoni et
al., 1995), a phenotype that was confirmed in our lab for the most important of these
surface markers (data not shown). FSDCs are adherent and present a morphology
consistent with a DC type, having an irregular shape and many surface projections
arising from the cell.
FSDCs were cultured in serum-containing endotoxin-free Iscove’s Modified
Dulbecco’s Medium (IMDM) supplemented with 10% (v/v) of inactivated fetal calf
serum, 3.02 g/l sodium bicarbonate, 100 U/ml penicillin, 100 g/ml streptomycin and 30
mM of glucose, in a humidified incubator with 5% CO2/95% air, at 37◦C. Indeed,
FSDCs did not require exogenous GFs for their continued proliferation.
FSDCs have a doubling time of about 48h and were used after reaching 80-90%
confluence, occurring every 7 days. Cells were subcultured (1:5) in plastic flasks of 75
or 150cm2, using trypsin to detach the cells from the flasks after a previous wash with
phosphate buffered saline (PBS). Afterwards, cells were centrifuged at 230g for 4min
and resuspended in fresh IMDM medium.
The BJ cell line was kindly supplied by Paula Marques and João Malva (Life
Sciences Department and Center for Neurosciences and Cell Biology, Coimbra
University, Portugal). This cell line was established from skin taken from normal
newborn human foreskin fibroblasts and is telomerase negative. Telomerase is a
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reverse-transcriptase enzyme that elongates the telomeres. Cells transfected with the
catalytic subunit of human telomerase (hTERT), although they are not transformed, do
not display replicative senescence when considered as cell populations (Bodnar et al.,
1998). Accordingly, the BJ cell line has the capacity to proliferate to a maximum of 72
population doublings before the onset of senescence.
BJ cells were cultured in serum-containing endotoxin-free Dulbecco's Modified
Eagle Medium (DMEM) supplemented with 10% (v/v) of inactivated fetal calf serum,
3.02 g/l sodium bicarbonate, 100 U/ml penicillin, 100 g/ml streptomycin and 30 mM of
glucose, in a humidified incubator with 5% CO2/95% air, at 37◦C. No exogenous GFs
were required for their continued proliferation.
BJ fibroblasts have a doubling time of about 72h and were used after reaching
80-90% confluence, which occurs approximately every 7 days. Cells were subcultured
(1:3) in plastic flasks of 150cm2 and identically detached, centrifuged and resuspended
as FSDCs. Along the experiments, cells were monitored by microscopic observation in
order to detect any morphological change.
3. Chemicals preparation
NT was dissolved in ultra-pure MiliQ H2O in a final concentration of 6 mM (10
mg/mL); LPS was dissolved and aliquoted in sterile PBS to achieve a final
concentration of 1 mg/mL and 0.1 mg/mL; the NTR inhibitor was dissolved and
aliquoted in sterile DMSO into a final concentration of 3.41 mM (2 mg/mL). Daily
dilutions were diluted in ultra-pure MiliQ H2O. These stocks solutions were aliquoted
and diluted into different concentrations and stored at -20ºC.
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4. MTT and griess reaction assays
4.1. MTT assay
The MTT assay is a standard colorimetric assay to measure the reduction
capacity of mitochondria and the activity of the mitochondrial dehydrogenases. MTT
(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) is a tetrazole yellow
compost that when cleaved by mitochondrial dehydrogenases converts into formazan, a
purple compost which is insoluble in water (Figure 9). After formazan dissolution in a
solubilisation solution, like isopropanol, the intensity of the colour of the purple
solution can be determined in a spectrophotometer, at a wavelength of 500-600nm.
Only living, viable and metabolic cells, with active dehydrogenases, are able to
reduce MTT. Accordingly, the amount of purple formazan produced by the cells will be
correlated with more viable cells, which means that there are more cells (in comparison
to a control situation) or that there are the same amount of cells, but with increased
dehydrogenase activity. Thus, this assay measures cell death or cells changing
metabolism. This method is usually used to determine composts cytotoxicity, as some
composts can have a great chemical potential but provoke cell toxicity (Mosmann T.,
1983).
Figure 9 – MTT reduction reaction (Mosmann T., 1983).
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4.2. Griess reaction
NO is a pleiotropic biological mediator, regulating diverse activities ranging
from neuronal function to immune system regulation. NO is produced via the reaction
of L-Arginine, NADPH, and O2 to NO and citrulline (Bredt D.S. & S.H. Snyder, 1990;
Moncada et al., 1989; Palmer et al., 1988a; Palmer et al., 1988b) and is catalyzed by
enzymes of the nitric oxide synthase (NOS) family, the neuronal (nNOS/NOS1),
endothelial (eNOS/NOS3), and inducible (iNOS/NOS2) nitric oxide synthase (Alderton
et al., 2001). The names of the enzymes are related to the local where these enzymes are
largely expressed. Usually, eNOS and nNOS are constitutively expressed and regulated
by Ca2+/Calmodulin, while iNOS is induced by endotoxin and inflammatory cytokines,
exhibiting some insensitivity to calcium (Alderton et al., 2001; Kone et al., 2003).
NO is not stored but is synthesized de novo and freely diffuses across lipid
membranes. Indeed, its action occurs essentially on target cells, via different
mechanisms. For example, it can activate the enzyme guanylyl cyclase and generate the
second messenger guanosine 3’,5’-cyclic monophosphate (cGMP), implicated in
diverse biological functions, like the regulation of smooth muscle contractility, cell
survival, proliferation, axon guidance, synaptic plasticity, inflammation, angiogenesis,
and the activity of cyclic nucleotide-gated channels (Arancio et al., 2001; Arancio et al.,
1996; Guzik et al., 2003; Hamad et al., 2003; Hood J. & H.J. Granger, 1998;
Kronemann et al., 1999; Lev-Ram et al., 1997; Suhasini et al., 1998; Zhuo et al., 1994).
In the present work, as FSDCs were treated with LPS, NO measurement gives
essentially the state of inflammation in cells. NO is measured through an indirect way,
by measuring the levels of NO metabolites, nitrite (NO2-) and nitrate (NO3-) (Marletta et
al., 1988; Tsikas et al., 2005; Wennmalm et al., 1993 and 1992), as they are more stable
metabolites. The assay is based on a chemical reaction of diazotization described by
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Griess (Griess P., 1879), which uses sulfanilamide and N-1-napthylethylenediamine
dihydrochloride (NED) under acidic (phosphoric acid) conditions (Figure 10).
Figure 10 – Griess Reaction (Corporation, 2009).
4.3. Cells treatment
FSDCs were stimulated with 1µg/ml of LPS, an in vitro model of inflammation,
and treated with different NT concentrations (10, 50 and 100 nM), for 5min to 1h and
during 1 to 7 days. Cell viability was determined by the reduction of MTT (Mosmann
T., 1983). NO production was evaluated by the colorimetric griess reaction that detects
nitrite in the supernatants of stimulated cells.
Briefly, FSDCs were plated at 2×105 cells/well in 48-well plates, in a final
IMDM volume of 600µL. LPS or/and NT stock solutions were added to obtain the
different final in-well concentrations studied. Subsequent to the incubations, 170µl of
the medium was collected to perform the griess reaction and then, 43µl of MTT solution
(5 mg/ml) was added to each well. Microplates were further incubated at 37ºC for 1h, in
a humidified atmosphere of 95% air and 5% CO2. Following, 300µl of acidic
isopropanol (0.04N HCl in isopropanol) was added to each well and mixed in order to
dissolve the dark blue crystals of formazan. Acidic isopropanol was collected to an
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ELISA microplate and formazan quantification was performed using an ELISA
automatic microplate reader (SLT, Austria) at 570nm, with a reference wavelength of
620nm.
The collected medium was placed in 96-well plates and diluted with equal
volume (170µl) of Griess reagent [0.1% (w/v) N-(1-naphthyl)ethylenediamine
dihydrochloride and 1% (w/v) sulphanilamide containing 5% (w/v) H3PO4], during
30min, in the dark. Finally, the absorbance was measured at 550nm. Culture medium
was used as blank and nitrite concentration was determined from a regression analysis
using serial dilutions of sodium nitrite as standard.
5. Microscopy
Microscopy can give us visible information about the state of cells. The
morphology of cells is crucial to determine if cells are viable/death, (in)activated or with
morphologic alterations. These parameters may direct us to a possible understanding of
the biological state of the cells. Indeed, cell morphology was regularly observed using
an optical microscope. FSDCs morphology was also analyzed when stimulated with
1µg/ml of LPS, or with LPS in the presence of 10, 50 or 100 nM of NT, or maintained
in IMDM medium containing 2% of inactivated fetal calf serum, during 1, 3, 5 and 7
days. Following incubations, photographs were taken using a coupled AxioCamMR3
camera with PALM reflector and 20X objective, using an inverted Axiovert 200
microscope with transmitted and reflected light transmission microscopy. Furthermore,
the FSDCs and BJ cytoskeleton, as well as, nucleus morphology after 24h of LPS/NT
treatment and BJ cell migratory properties after 24h of LPS/NT treatment were also
determined and will be subsequently described.
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5.1. Scratch Assay
The in vitro scratch assay is a cost-effective method to study cell migration in
vitro. This method involves the formation of a new artificial gap - ‘‘scratch’’ - on a
confluent cell monolayer, where cells from the confluent non-gapped area move to the
newly created gap through cell migration, until cell–cell contacts are established again.
The principal steps of this method are: formation of a ‘‘scratch’’ on the cell monolayer,
image capturing in the beginning and the end of cell migration (closure of the scratch),
and finally, comparison of the images to determine the rate of cell migration (Liang et
al., 2007).
BJ cells (4x105) were resuspended in 3mL of DMEM medium in µ-Dish35mm, high
(Ibidi) and left in the incubator overnight to stabilize. After stabilization, the medium
was changed and, with a p200 pipette tip, a ‘‘scratch’’ was made in the cell monolayer
in a straight line to create a ‘‘scratch’’ area without cells. The medium was immediately
removed and cells were washed two to three times with PBS 1X. Following, DMEM
medium containing 2% of inactivated fetal calf serum was added to the cells to diminish
cell proliferation. Photographs were captured with a coupled AxioCamMR3 camera
with PALM reflector and 20X objective, using an inverted Axiovert 200 microscope
with transmitted and reflected light, choosing a specific and numbered/lettered area to
permit later recognition of the photographed area. Afterwards, BJ cells were incubated
with 1µg/ml of LPS, or with LPS in the presence of 10/100nM of NT, or maintained in
DMEM medium containing 2% of inactivated fetal calf serum (control) and allowed to
migrate during 24h. After the incubation period, photographs were taken in the same
area where the first photograph was taken. Photographs were analyzed and the number
of cells in the scratch area was counted.
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5.2. Immunocytochemistry assay
Immunocytochemistry assay was performed to analyze actin network of the
cells. Accordingly, cells were fixed to preserve normal cell structure and permeabilized
to permit the antibody entry into the cells. Cells were incubated with antibodies that
target specific peptides or protein antigens in the cell via specific epitopes, like the
antibody used in this work for actin - phalloidin. Phalloidin is an antibody which uses
Phallotoxins properties, which are a group of bicyclic heptapeptides from poisonous
mushrooms that bind actin filaments (Cooper et al., 1987). Usually, after incubation
with the primary antibody, cells are incubated with a secondary antibody, conjugated
with a fluorofore that binds to the primary antibody. However, the antibody used in the
present work was already conjugated with the fluorofore Alexa Fluor 555. Moreover,
cells were stained with 4',6-diamidino-2-phenylindole (DAPI), which is a blue
fluorescent probe that fluoresces brightly upon selectively binding to the minor groove
of double stranded DNA (Kapuscinski J., 1995).
FSDCs (5×105) and BJ cells (2×105) were cultured in 24-well plates with lamella
and stimulated with 1µg/ml LPS, or treated with 10/100nM of NT, or stimulated with
1µg/ml LPS and treated with 10/100 nM of NT, or left untreated (control), during 24h.
After incubation, cells were washed with ice-cold PBS, fixed with 4%
paraformaldehyde in PBS for 10min, and then permeabilized with 0.1% Triton X-100 in
PBS containing 200 mM glycine, during 5min. After a blocking step with 1% BSA, for
30min, cells were incubated with Alexa Fluor 555 phalloidin antibody (1:500) for
30min at room temperature and washed three times with PBS. Then, cells were
incubated for 1min with DAPI (0.1 μg/ml in PBS) and mounted with Vectashield
medium to reduce photobleaching. For image acquisition, fluorescence labelling was
visualized using a fluorescence microscope - Zeiss Axiovert 200 - and images captured
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with a coupled AxioCamHR camera. In each experiment, the optimal acquisition
parameters were defined for the control cells and then maintained for all the other
conditions within the same experiment. The filter set used included an excitation filter
of 560nm and an emission filter of 575nm for Alexa Fluor 555 and an emission filter of
420nm for DAPI. The settings for contrast, brightness, pinhole, acquisition mode and
scanning time were maintained throughout the work (Neves et al., 2009).
6. Western blot (WB)
6.1. Cell lysates preparation for WB analysis
FSDCs cells (7,5x105) were plated in 12-well plates and incubated overnight to
adhere to the bottom of the wells. Then, cells were treated with 10nM of NT or/and 1µg
of LPS during 5, 15, 30 and 60min. After incubation, cells were washed with ice-cold
PBS and harvested in a sonication buffer containing 50 mM Tris HCl pH 8, 150 mM
NaCl, 1% NP-40 (Nonidet P-40), 0.5% Sodium Deoxycholate, 0.1% SDS, 2 mM
EDTA, proteases inhibitor cocktail, fosfatases inhibitor cocktail and DTT 1 mM. Cell
lysates were sonicated three times, during 4sec, at 40µm in a Vibra Cell sonicator
(Sonics & Material INC), to disrupt cells. Following, cell lysates were submitted to
centrifugation (14,000g for 10min) and the supernatant was collected. Protein
concentration was determined using the bicinchoninic acid (BCA) method and then, cell
lysates were denatured at 95ºC, for 5min, in sample buffer (0.5 M Tris HCl pH 6.8; 10%
(w/v) SDS; 0.6 M DTT; 30% (v/v) glycerol and 0.01% bromophenol blue).
6.2. Protein quantification by the bicinchonininc acid (BCA) method
BCA method is a copper-based protein assay used for protein quantification,
sustained on the well-known "biuret reaction", whereby peptides containing three or
more aminoacid residues form a colored chelate complex with Cu2+, in an alkaline
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environment containing sodium potassium tartrate. The BCA method involves two
different step reactions: the biuret reaction, whose blue color results from the reduction
of Cu+2 to Cu+1 by proteins; and the BCA chelation with Cu+1, resulting in an intense
purple color (Figure 11). The purple colored reaction product is formed by the chelation
of two molecules of BCA with one cuprous ion. The purple product absorbs strongly at
540-570nm, which absorption can be read in a spectrophotometer. Since the production
of copper in this assay is a function of protein concentration and incubation time, the
protein content of unknown samples may be determined spectrophotometrically by
comparison with known protein standards. Indeed, at the same time, the absorption of
Bovine serum albumin (BSA) of increasing concentrations between 12.5 μg/mL and
800μg/mL was determined and used as a standard linear curve to determine protein
concentration. Indeed, equal amounts of diluted protein samples (1:9) and water or BSA
dilutions and the sample buffer RIPA in a final volume of 50µL were added to an Elisa
plate. Then, 200µL of BCA reagent was added to the wells and the plate was incubated
in the dark for 30min, at 37ºC. After incubation, the absorption was measured in ELISA
Figure 11 – Schematic reaction for the bicinchoninic acid (BCA)-
containing protein assay (Pierce , 2009).
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automatic microplate reader (SLT, Austria) at 570nm. This method is not affected by a
range of detergents and denaturing agents such as urea and guanidinium chloride,
although it is more sensitive to the presence of reducing sugars (Pierce, 2009).
6.3. SDS-PAGE, PVDF transfer and WB analysis
WB was used to determine proteins levels inside of the cell: the total amount of
a determined protein or the phosphorylated amount of a determined protein inside of the
cell. This technique gives us information about the levels of proteins and also
phosphorylated proteins, which can indicate the activation of signaling pathways.
WB was performed to evaluate the levels of IB-α, p-ERK1/ERK2, p-p38
MAPK, p-SAPK/JNK and p-Akt protein levels. Each gel was loaded always with the
same amount of protein, which was 20 to 80µg (depending on the quantity needed to
observe the protein band). Proteins were separated by electrophoresis (140 Volt during
60 to 70min) on a 10% (v/v) sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE), and transferred to polyvinylidene fluoride (PVDF) membrane. After
electrophoresis and transfer, membranes were blocked with 5% (w/v) fat-free dry milk
in Tris-buffered saline containing 0.1% (v/v) Tween 20 (TBS-T), for 1h at room
temperature. Subsequently, blots were incubated overnight at 4ºC (p-ERK, p-JNK and
IKB-α) or at room temperature (p-p38 and p-Akt) with the primary antibodies against
the different proteins to be studied: IkBα (1:1000); p-ERK1/ERK2 (1:1000); p-p38
MAPK (1:1000); p-JNK (1:1000) and p-Akt (1:500). After incubation, membranes were
washed three times for 15min with 0.1% TBS-T and incubated for 1h at room
temperature, with alkaline phosphatase-conjugated anti-rabbit antibody (1:5000), or
alkaline phosphatase-conjugated anti-mouse antibody (1:5000). The immune complexes
were detected by membrane exposure to the ECF reagent, during 4 to 6min, followed by
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scanning for blue excited fluorescence on the VersaDoc (Bio-Rad Laboratories,
Amadora, Portugal). The generated signals were analyzed using the Image-Quant TL
software.
To test whether similar amounts of protein for each sample were loaded, the
membranes were stripped and reprobed with antibodies for total ERK1/2, SAPK/JNK,
p38 MAPK and Akt, or with an antibody for β-actin, and blots were developed with
alkaline phosphatase-conjugated secondary antibodies and visualized with ECF. The
stripping was performed after PVDF membrane activation: 10sec in methanol, twice
washing for 15min, incubation with water, 0.2 M of NaOH and water for 5min; finally,
incubation with the blocking solution and reprobing the total protein antibodies were
performed.
7. Real-time reverse transcription by polymerase chain reaction
(real-time RT-PCR or qRT-PCR)
7.1. RNA extraction
FSDCs (2×106) or BJ cells (8×105) were plated in 6-well plates or 60mm dishes
in a final volume of 4 or 6ml, respectively. Cells were treated with 1µg/ml of LPS
during 6h and/or 10/100 nM of NT during 6h, or pre-treated with 10/100nM of NT
during 24h and stimulated with 1 µg/ml of LPS during 6h, or left untreated (control).
Total RNA was isolated from these cells with the TRIzol® reagent according to the
manufacturer’s instructions, to later determine the transcription levels of different
molecules in the cell. Briefly, cells were washed with ice-cold PBS, harvested and
homogenized in 1ml of Trizol by pipetting vigorously. After addition of 200µl of
chloroform, samples were vortexed, incubated for 2min at room temperature and
centrifuged at 12,000g, for 1min, at 4◦C. The aqueous phase containing RNA was
transferred to a new tube, and then RNA precipitated with 500µl of isopropanol after
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10min centrifugation at 12,000g. The pellet was washed with 1ml of 75% ethanol and
resuspended in 100µl of 60◦C heated RNase free water. The RNA concentration was
determined by OD260 measurement using a Nanodrop spectrophotometer (Wilmington,
DE, USA). RNA was stored in RNA Storage Solution (Ambion, Foster City, CA, USA)
at −80◦C.
7.2. Real-time RT-PCR
In the real-time RT-PCR technique total RNA is initially converted into cDNA,
by reverse transcription. A specific sequence of the cDNA (the gene in study) is
amplified using specific primers, and the inclusion of a fluorescent dye allows the
detection of the reaction progress in real time. Finally, real-time RT-PCR allows the
measurement of gene amplification, important to compare the amount of gene
expression in the cell, in a control or treatment situation.
One microgram of total RNA was reverse transcribed using High Capacity
cDNA Reverse Transcription (RT), from Applied Byosistems. Briefly, 2µl of 10X RT
Buffer, 0.8µl of 25X dNTP Mix, 2µl of 10X RT random primers, 1µl of MultiscribeTM
Reverse Transcriptase and 4.2µl of nuclease free H20 were added to 10µl of RNA (1µg)
sample. A protocol for cDNA synthesis was run on all samples (10min at 25◦C, 120min
at 37◦C, 5min at 85◦C and then put on hold at 4◦C). After the cDNA synthesis, the
samples were diluted with RNase-free water up to a volume of 100µl and concentration
of 0.01 µg/µl.
Real-time RT-PCR was performed in a 20µl volume containing 2.5µl cDNA
(25ng), 10µl 2X Syber Green Supermix, 2µl of each primer (250 nM) and 1µl of H2O
PCR grade. Samples were denatured at 95◦C during 3min. Subsequently, 40 cycles were
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run for 10sec at 95◦C for denaturation, 30sec at the appropriate annealing temperature
and 30sec at 72 ◦C for elongation.
Real-time RT-PCR reactions were run in duplicate for each sample on a Bio-Rad
My Cycler iQ5. Primers were designed using Beacon Designer® Software v7.2, from
Primier Biosoft International and thoroughly tested. Primer sequences are given in
Table I. On each real-time RT-PCR plate there was a non-template control present for
each pair of primers analyzed. For determination of primer-pair specific efficiencies, a
four point dilution series of the control sample for each pair of primers was run on each
experiment. Amplification reactions were monitored using a SYBR-Green assay. After
amplification, a threshold was set for each gene and Ct-values were calculated for all
samples. Gene expression changes were analyzed using the built-in iQ5Optical system
software v2. The software enables analyzing the results with the Pfaffl method (Pfaffl,
M., 2001), a variation of CT method corrected for gene-specific efficiencies, and to
report gene expression changes as relative fold changes compared to the control
samples. The results were normalized using a reference gene, hypoxanthine
phosphoribosyltransferase 1 (HPRT-1), an enzyme that primarily function to salvage
purines from degraded DNA to renewed purine synthesis, acting as a catalyst in the
reaction between guanine and phosphoribosyl pyrophosphate to form GMP. This
reference gene was previously validated in our lab (Neves et al., 2009) and its
expression did not suffer variations upon FSDCs and BJ cell lines stimulation with LPS
and NT.
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Table I - Primer sequences for targeted cDNAs.
Primer 5’-3’Sequence (F:Forward; R-Reverse) RefSeqID Source
HPRT1 F: GTTGAAGATATAATTGACACTGR: GGCATATCCAACAACAAAC NM_013556 Mouse
NT F: AATGTTTGCAGCCTCATAAATAACR:TGCCAACAAGGTCGTCATC NM_024435 Mouse
NTR1 F: GGCAATTCCTCAGAATCCATCCR: ATACAGCGGTCACCAGCAC NM_018766 Mouse
NTR2 F: GCCATTACTAACAGTCTAAGCR: GCAATTCGTCCTATTCTACAC NM_008747 Mouse
NTR3 F: ATGGCACAACTTCCTTCTGR: AGAGACTTGGAGTAGACAATG NM_019972 Mouse
IL-1β F: ACCTGTCCTGTGTAATGAAAGR: GCTTGTGCTCTGCTTGTG NM_008361 Mouse
IL-6 F: TTCCATCCAGTTGCCTTCR: TTCTCATTTCCACGATTTCC NM_031168 Mouse
IL-10 F: CCCTTTGCTATGGTGTCCTTTCR: ATCTCCCTGGTTTCTCTTCCC NM_010548 Mouse
TNF-α F: CAAGGGACTAGCCAGGAGR: TGCCTCTTCTGCCAGTTC NM_013693 Mouse
IFN-δ F: CTTCTTGGATATCTGGAGGAACTGR: GGTGTGATTCAATGACGCTTATG NM_008337 Mouse
G-CSF F: TCATTCTCTCCACTTCCGR: CTTGGTATTTACCCATCTCC NM_009971 Mouse
CCL5 F: CACTCCCTGCTGCTTTGCR: CACTTGGCGGTTCCTTCG NM_013653 Mouse
VEGF-A F: CTT GTT CAG AGC GGA GAA AGCR: ACA TCT GCA AGT ACG TTC GTT NM_001025250 Mouse
EGF F:  GCA CAG TTT GTC TTC AAT GGCR: TGT TGG CTA TCC AAA TCG CCT TGC NM_010113 Mouse
PDGF-
BB
F: ATT AGA GGT GCA GTG TGC GTG TGA
R: AGG GCA CAT GAG GAA GAA GAC ACA NM_011057 Mouse
IRS-1 F: ACC GAC GCA TGG TCT ATG TTG CTAR: AAA CCT GGC CTG GTA CCC ATT ACA NM_010570 Mouse
GLUT4 F: AAC GGA TAG GGA GCA GAA ACC CAAR: GTG CAA AGG GTG AGT GAG GCA TTT NM_009204 Mouse
HPRT1 F: TGACACTGGCAAAACAATGR: GGCTTATATCCAACACTTCG NM_000194 Human
NT F: GCATACATCAAAGATTAGTR: TAAAGCAGTAGGAAGTTT NM_006183 Human
NTR1 F: GTCGTCATACAGGTCAACR:GATGATGGTGTTCAGGAC NM_002531 Human
NTR2 F: GCAAGAATGAACAGAACAR: GAATGATTAGTGATGAGGTT NM_012344 Human
NTR3 F: TGGGTTGGAGATAGCACTGGR: ACGACTTCCTCCAGACACCT NM_002959 Human
IL-1β F: GCTTGGTGATGTCTGGTCR:  GCTGTAGAGTGGGCTTATC NM_000576 Human
IL-6 F:  TCTGGATTCAATGAGGAGACTTGR: TCACTACTCTCAAATCTGTTCTGG NM_000600 Human
IL-8 F: CTTTCAGAGACAGCAGAGR: CTAAGTTCTTTAGCACTCC NM_000584 Human
CCL11 F: ACCAGAGCCTGAGTGTTGR:TGCCCTTTGGACTGATAATGA NM_002986 Human
CCL4 F:CGCCTGCTGCTTTTCTTACACR:CAGACTTGCTTGCTTCTTTTGG NM_002984 Human
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Legend: Hypoxanthine phosphoribosyltransferase 1 (HPRT1); Neurotensin
(NT); Neurotensin receptor (NTR) Interleukin (IL); Tumor necrosis factor
(TNF); Interferon (IFN); Granulocyte colony-stimulating factor (G-CSF);
Vascular endothelial growth factor (VEGF); Epidermal growth factor (EGF);
Platelet-derived growth factor (PDGF); Insulin receptor substrate-1 (IRS-1);
Glucose transporter 4 (GLUT4).
7.3. Calculation of real-time RT-PCR results
Since the real-time RT-PCR results are presented as ratios of treated samples
over untreated (control) or LPS treated cells, the distribution of the data does not follow
a normal distribution. Therefore, a two-base logarithmic transformation was therefore
used to make observations symmetric and closer to a normal distribution. If x represent
the fold change of a gene in one sample, then the two-base logarithmic transformation
is: log2(x) = ln(x1)/ln(2). This way, fold changes of 2 and 0.5 correspond to mean log2
values of 1 and −1, respectively.
8. Statistical analysis
The results are presented as mean ± S.D. of the indicated number of
experiments, and the statistic difference between two groups was determined by the
two-sided unpaired Student’s t test. For multiple group comparisons, the One-Way
ANOVA test, with a Dunnett’s or Bonferroni´s Multiple Comparison post-test was
used. The tests were performed using GraphPad Prism, version 5.02 (GraphPad
Software, San Diego, CA, USA). Statistically significant values are as follows:
*P<0.05, **P<0.01, ***P<0.001.
CCL5 F: CAGTGAGCTGAGATTGTGR:TTTGTTGTTGTTGTTGTGA NM_002985 Human
VEGF-A F:CACTAGCTTATCTTGAACR:ATAGTATGTAGATGTATATTGAA NM_001025366 Human
EGF F: TCAGAAGATAACATTACAGAATR: AATACACCGAGCATACAT NM_001178130 Human
IRS-1 F:  AGTCCCAGCACCAACAGAACR: TCATCCGAGGAGATGAAACC NM_005544 Human
GLUT4 F:  AGGTGAAACCCAGCACAGAACTTGR:  AGAGGGTTAAAGTGCTGCAGAGGA NM_001042 Human
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1. Neurotensin and neurotensin receptors
The presence of NTRs, namely NTR1, NTR2 and NTR3, was determined in
untreated cells (control) and in cells exposed to LPS during 30min. It was observed that
NTR1 and NTR3 were constitutively expressed in FSDCs (Figure 12), as it can be
observed by WB analysis. In contrast, the NTR2 seemed not to be expressed by FSDCs,
as it was not detectable by WB analysis. Additionally, LPS did not modify the protein
levels of NTR1 and NTR3 (Figure 12). As WB analysis gave essentially qualitative
information about the presence of the receptors, we next confirmed the absence of
NTR2 by real-time RT-PCR analysis in untreated cells (control) and in cells exposed to
LPS during 6h. Furthermore, as these receptors are present at the cell surface, in cell
membranes, or internalized as a receptor–ligand complex, the methods used to obtain
cell extracts could not had been effective enough to achieve these receptors and quantify
them. In addition, NTRs mRNA levels in normal and stimulated conditions can be
evaluated with more accuracy by real-time RT-PCR. Indeed, accordingly to WB results,
NTR1 and NTR3 were expressed in FSDCs, while NTR2 was almost absent.
Comparing the relative amounts of the transcripts, NTR3 appeared to be the most
expressed among the analyzed NTRs receptors (Figure 13). The treatment of cells with
LPS during 6h caused a decrease on the transcription of all studied NTRs, by -1.14 ±
0.55 (n=3), -1.88 ± 0.77 (*p<0.05, n=3) and -0.85 ± 0.78 (n=3) fold, for NTR1, NTR2
and NTR3 expression relatively to the control (Figure 14). The effect of NT in NTR3
expression was also analyzed by RT-PCR in untreated cells (control) and cells exposed
to 10 nM of NT during 6h. It was observed that NT increased NTR3 mRNA expression
by 0.94 ± 0.68 (n=3) fold (data not shown). Furthermore, NT was not constitutively
expressed in FSDCs (Figure 13), however, LPS caused a 3.75 ± 0.50 (***p<0.0001,
n=3) fold-increase relatively to the control (Figure 14).
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Figure 12 – NTRs (NTR1 and NTR3) expression in FSDCs by WB
analysis. NTR2 expression was not detectable by WB analysis.
FSDCs were maintained in IMDM medium (control), or incubated with
1µg/ml of LPS during 30min. Total cell extracts were subjected to SDS-
PAGE, transferred to PVDF membranes and subjected to WB analysis, using
the NTR1, NTR2 and NTR3 antibodies. The blot shown is representative of
3 independent experiments yielding similar results.
Figure 13 – NT and NTRs (NTR1, NTR2 and NTR3) were differentially
expressed in FSDCs.
Cells were plated at 2×106 cells/well in 6-well microplates in a final volume
of 6 ml of medium, at 37◦C, with 5% CO2. Total RNA was isolated and
retrotranscribed as indicated in experimental procedures. The mRNA levels
were assessed by quantitative real-time RT-PCR. Gene expression is
indicated as genes studied/10 000 molecules of the reference gene HPRT1.
Each value represents the mean±S.D. from three independent experiments.
Ctrl      30’LPS
NTR1 NTR3
Ctrl      30’LPS
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Figure 14 – NT and NTRs (NTR1, NTR2 and NTR3) were differentially
expressed in inflammatory conditions, in FSDCs.
FSDCs were maintained in IMDM medium (control) or were incubated with
1µg/ml of LPS during 6h. Total RNA was isolated and retrotranscribed as
indicated in experimental procedures. The mRNA levels were assessed by
quantitative real-time RT-PCR. Gene expression is indicated as mean log2
values of fold changes relatively to the control. Each value represents the
mean±S.D. from three independent experiments (*p < 0.05; ***p < 0.001
unpaired two-tailed t-student test).
2. The effect of neurotensin on FSDCs viability
FSDCs were incubated with 10, 50 and 100 nM of NT, from 5 to 60min, in order
to evaluate if NT provoked toxicity to the cells. None of the three concentrations tested
caused mortality to the cells. Even so, 10 nM of NT was able to slightly increase FSDCs
viability (28% for all time exposures) (Figure 15A). Cells were also incubated with LPS
alone or in the presence of different concentrations of NT. Cell viability was not
affected by these compounds; furthermore, 10 and 50 nM of NT slightly increased cell
viability, after 5min of incubation (Figure 15B).
FSDCs were also incubated with 10, 50 and 100 nM of NT, from 1 to 7 days, to
determine if NT was toxic to the cells during long-time periods of incubation (Figure
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16A). All NT concentrations barely diminished FSDCs viability. However, 10 nM of
NT was the harmless concentration at the first day (cell viability increased 5% and 13%
relatively to the 50 and the 100 nM concentrations), although 50 nM of NT was the
most efficient concentration at the third day (cell viability increased 12% and 6%
relatively to the 10 and 100 nM concentrations) and, 100 nM at the fifth day (cell
viability increased 17% of the mean, versus the 10 and 50nM concentrations) and at the
seventh day (cell viability increased 15% and 8% relatively to the 10 and the 50 nM
concentrations).  At the seventh day, the viability was maintained similar to the control
(100 ± 17%)  (Figure 16A). FSDCs were also incubated with LPS and different
concentrations of NT from 1 to 7 days (Figure 16B) and the results demonstrated that
along the 7 days, cells treated with LPS and 10 nM of NT showed a decrease on cell
viability (from 4% to 14%) than cells only treated with LPS. However, cells treated
with LPS and 100 nM of NT demonstrated a tendency to more viability when compared
to cells treated with only LPS at short (31% at day 1) and long-time incubation periods
(6% and 7% at day 5 and 7). Taking into account the long period of incubation, none of
these compounds significantly affected cell viability.
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Figure 15 – NT did not affect FSDCs viability during short-time periods
of incubation.
FSDCs were maintained in IMDM medium (control), or were incubated with
10, 50 or 100 nM of NT, or with 1µg/ml of LPS in the presence of 10, 50 or
100 nM of NT, during 5, 15, 30 or 60min. Cell viability was determined by
the MTT reaction. The results were expressed as % of MTT reduction
relatively to the control. Each value represents the mean from 2 experiments,
performed in duplicate.
A
B
A
B
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Figure 16 – FSDCs viability was slightly and differentially modulated
by distinct NT concentrations, during long-time periods of incubation.
FSDCs were maintained in IMDM medium (control), or incubated with 10,
50 or 100 nM of NT, or with 1µg/ml of LPS in the presence of 10, 50 or 100
nM of NT, during 7 days. In the last day, the viability of the cells was
determined by the MTT reaction. The results were expressed as % of MTT
reduction relatively to the control. Values were compared using one-way
ANOVA followed by the Dunnett’s comparison test for each day relatively
to LPS. Each value represents the mean  SD from 3 experiments,
performed in duplicate (*p<0.05).
A
A
B
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3. iNOS expression and nitrite production
FSDCs were maintained in IMDM medium or incubated with 1 µg/mL of LPS
during 6h. After incubation, total RNA was isolated from cells, quantified and reverse
transcribed to cDNA, to finally perform real-time RT-PCR. FSDCs highly expressed
iNOS which was upregulated by the LPS stimulus (data not shown). Thus, iNOS
expression might have represented an elevated iNOS production and, per se, high
iNOS-regulated NO production. Furthermore, NO production was analyzed in NT
treaded cells, with or without LPS, during 1 to 7 days.
FSDCs were incubated with 10, 50 and 100 nM of NT to determine nitrite
levels. All NT treatments diminished nitrite production (data not shown). Cells were
also incubated with LPS and LPS-treated cells were incubated with different
concentrations of NT, from 1 to 7 days. In comparison with control cells, LPS increased
nitrite levels to 4484 ± 1454% (n=3) relatively to the control in the first day, followed
by a decrease till the seventh day. Additionally, it was observed that at day 1, in LPS-
treated cells simultaneously exposed to NT, all NT concentrations tended to increase
nitrite levels, being this increase lower for 10 nM and higher for 100 nM. In the 3rd, 5th
and 7th days, 10 nM of NT tended to diminish nitrite production, while 50 and 100 nM
of NT tended to increase nitrite production. These effects were not statistically
significant (n=3) (Figure 17).
Taken together, FSDCs treatment with NT decreased nitrite production and in
the presence of LPS, 10nM of NT was able to decrease nitrite levels, in contrast to 50
and 100 nM of NT that increased nitrite levels.
B
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Figure 17 – NT modulated nitrite production in FSDCs.
FSDCs were maintained in IMDM medium (control), or with 1 µg/mL of
LPS, or with LPS in the presence of 10, 50 or 100 nM of NT, during 7 days.
Culture medium was collected every 2 days and used for nitrite
determination, by the griess reaction. The results were expressed as % of
nitrite production by control cells. Values were compared using one-way
ANOVA followed by the Dunnett’s comparison test. Each value represents
the mean  SD from 3 independent experiments, performed in duplicate.
4. Activation of intracellular signaling cascades
FSDCs were incubated with 10 nM of NT during 5, 15, 30 and 60min, to
evaluate the effect of the neuropeptide on intracellular signaling pathways activation.
WB analysis was performed to detect the phosphorylated form of the MAP kinases
(ERK1/ERK2, SAPK/JNK and p38 MAPK) and Akt. The involvement of the
transcription factor NF-B was also evaluated by the determination of protein levels of
its inhibitory protein IB-α.
NT upregulated IB-α levels, activated Akt and slightly activated p38 MAPK.
By contrast, ERK and SAPK/JNK MAP kinases signaling pathways were not
significantly activated (Figure 18). The NF-B inhibitory protein – IBα – was not
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degraded and it even seemed to be increased in a time-dependent manner till 30min,
indicating the inhibition of NF-B (Figure 19). FSDCs were also incubated with 1
µg/ml of LPS and 10 nM of NT during 5, 15, 30 and 60min, to determine the effect of
NT on LPS-induced intracellular signaling pathways activation. The results obtained
with 100 nM of NT were similar to those obtained with 10 nM, therefore the
experiments were performed with 10 nM of NT. Upon LPS stimulation, maximal
ERK1/ERK2, SAPK/JNK, p38 MAPK and Akt phosphorylation was observed between
15 and 30min, being this activation more notorious in the ERK1/ERK2 signaling
pathway as it appeared to be more activated than the others. The inhibitory protein of
NF-B – IBα – diminished in a time-dependent manner until 30min, indicating the
activation of NF-B. When NT was added simultaneously as a second stimulus, p38
MAPK and ERK1/ERK2 signaling pathways were upregulated essentially at 30min,
while the SAPK/JNK signaling pathway was downregulated at 30min, when compared
with the results obtained with LPS alone. Between 5 and 15min, NT also provoked an
increase of the inhibitory protein of NF-B – IBα – diminishing NF-B activation. No
alteration was observed in the Akt signaling pathway when cells were incubated with
NT and LPS, in comparison with LPS alone. Results are represented in Figures 20 to
24. The same results were obtained when NT was added 30min before LPS or with cells
incubated with 100 nM of NT (data not shown). When NTR1 was inhibited with
SR48692, inactivation/activation of the signaling pathways returned to normal. WB
bands were quantified for the experiments in which NT modulated the signaling
pathways studied.
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100nM of NT10nM of NT
Ctrl         5’          15’        30’         60’          5’          15’        30’        60’
Figure 18 – NT modulated the activation of significant inflammatory
signaling cascades in FSDCs.
FSDCs were maintained in IMDM medium (control), or were incubated with
10nM of NT, during 5, 15, 30 or 60min. Total cell extracts were subjected to
SDS-PAGE, transferred to PVDF membranes and subjected to WB analysis,
using antibodies to p-ERK1/2, p-JNK, p-p38 and p-Akt. The activation of
NF-B was evaluated by the determination of the levels of its inhibitory
protein, IkB-α (WB band on the bottom). Equal loading was evaluated with
antibodies to ERK1/2, SAPK/JNK, p38 MAPK and Akt or with an anti-actin
antibody. The results were expressed as % of intensity relatively to the
control. The blots shown are representative of at least three independent
experiments yielding similar results.
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Figure 19 – Quantification of the expression levels of IB-α by WB,
normalized to β-actin antibody.
FSDCs were maintained in IMDM medium (control), or were incubated with
10 nM of NT, during 5, 15, 30 or 60min. Total cell extracts were subjected
to SDS-PAGE, transferred to PVDF membranes and subjected to WB
analysis. The activation of NF-B was evaluated by the determination of the
levels of its inhibitory protein, IB-α, and normalized to β-actin antibody.
The results were expressed as % of IB-α production relatively to the
control. The graphic shown is representative of at least 3 independent
experiments yielding similar results. Each value represents mean±SD.
Figure 20 - Determination of p-Akt/Akt expression by WB analysis.
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Figure 20 (continued) - FSDCs were maintained in IMDM medium
(control), or were incubated with 1µg/ml of LPS, or with LPS in the
presence of 10 nM of NT, or in the presence of 10 nM of NT and NTR1
inhibitor (I), during 5, 15, 30 or 60min. Total cell extracts were subjected to
SDS-PAGE, transferred to PVDF membranes and subjected to WB analysis,
using p-Akt antibody, normalized to Akt antibody, respectively. The blot
shown is representative of at least 3 independent experiments yielding
similar results.
Figure 21 – Determination of IB-α/β-actin expression by WB analysis.
Quantification of WB bands was evaluated with normalization to β-
actin antibody.
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Figure 21 (continued) - FSDCs were maintained in IMDM medium
(control), or were incubated with 1µg/ml of LPS, or with LPS in the
presence of 10 nM of NT, or in the presence of 10 nM of NT and NTR1
inhibitor (I), during 5, 15, 30 or 60min. Total cell extracts were subjected to
SDS-PAGE, transferred to PVDF membranes and subjected to WB analysis.
The activation of NF-B was evaluated by determination of the levels of its
inhibitory protein, IB-α (WB band on the bottom), and normalized to β-
actin antibody. The blot shown is representative of at least 3 independent
experiments yielding similar results. The results were expressed as % of
IB-α expression relatively to the control. Each value represents mean±SD
(*p < 0.05 t-student test, comparing treatments and stimulus of the same
time set).
Figure 22 - Determination of p-ERK/ERK bands by WB analysis.
Quantification of WB bands was evaluated with normalization to ERK
antibody.
FSDCs were maintained in IMDM medium (control), or were incubated with
1µg/ml of LPS, or with LPS in the presence of 10 nM of NT, or in the
presence of 10 nM of NT and NTR1 inhibitor (I), during 5, 15, 30 or 60min.
Total cell extracts were subjected to SDS-PAGE, transferred to PVDF
membranes and subjected to WB analysis, using p-ERK antibody,
normalized to ERK antibody. The blot shown is representative of at least 3
independent experiments yielding similar results. The results were expressed
as % of p-ERK expression relatively to the control. Each value represents
mean±SD (t-student test, comparing treatments and stimulus of the same
time set).
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Figure 22 (continued).
Figure 23 - Determination of p-JNK/JNK bands by WB analysis.
Quantification of WB bands was evaluated with normalization to JNK
antibody.
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Figure 23 (continued) - FSDCs were maintained in IMDM medium
(control), or were incubated with 1µg/ml of LPS, or with LPS in the
presence of 10 nM of NT, or in the presence of 10 nM of NT and NTR1
inhibitor (I), during 5, 15, 30 or 60min. Total cell extracts were subjected to
SDS-PAGE, transferred to PVDF membranes and subjected to WB analysis,
using p-JNK antibody, normalized to JNK antibody. The blot shown is
representative of at least 3 independent experiments yielding similar results.
The results were expressed as % of p-JNK expression relatively to the
control. Each value represents mean±SD (t-student test, comparing
treatments and stimulus of the same time set).
Figure 24 - Determination of p-p38/p38 expression by WB analysis.
Quantification of WB bands was evaluated with normalization to p38
antibody.
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Figure 24 (continued) - FSDCs were maintained in IMDM medium
(control), or were incubated with 1µg/ml of LPS, or with LPS in the
presence of 10 nM of NT, or in the presence of 10 nM of NT and NTR1
inhibitor (I), during 5, 15, 30 or 60min. Total cell extracts were subjected to
SDS-PAGE, transferred to PVDF membranes and subjected to WB analysis,
using p-p38 antibody, normalized to p38 antibody. The blot shown is
representative of at least 3 independent experiments yielding similar results.
The results were expressed as % of p-p38 expression relatively to the
control. Each value represents mean±SD (t-student test, comparing
treatments and stimulus of the same time set).
5. The effect of glucose and LPS on FSDCs
FSDCs were cultured in IMDM medium with 30 mM of glucose to reproduce
hyperglycemic conditions observed in diabetic patients. To determine if an increase in
glucose levels alter Insulin receptor substrate 1 (IRS-1) and Glucose transporter type 4
(GLUT4) expression in FSDCs, cells were also cultured at 25 mM of glucose.
Additionally, FSDCs response to different glucose levels was also analyzed in an
inflammatory environment, by stimulating FSDCs with LPS, during 6h.
The expression of IRS-1 and GLUT4 was studied in cells cultured in the
presence of either 25 or 30 mM of glucose. Firstly, FSDCs cultured in 25mM of glucose
exhibited both IRS-1 and GLUT4 expression, showing 17.22 ± 24.78 and 33.21 ± 22.93
(n=3) expression per reference gene, indicating that insulin signaling and GLUT4
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trafficking may occur in these cells. Secondly, cells cultured in higher glucose levels
(30 mM) had higher IRS-1 and GLUT4 expression, by 82.50 ±74.04 and 110.83 ± 85.62
(n=3) expression per reference gene, when compared to cells cultured with 25 mM of
glucose (Figure 25A). However, the mechanism by which this process occurred was not
elucidated in this work. The expression of IRS-1 and GLUT4 was also studied in cells
cultured with 25 and 30 mM of glucose, in inflammatory conditions (6h of LPS
stimulus). The main conclusions to retain from this study were a tendency in IRS-1 to
decrease by -2.60 ± 1.46 (n=3) fold in cells cultures with 30mM of glucose and in
inflammatory conditions relatively to the control (Figure 25B). Indeed, during
inflammatory conditions, insulin signaling might be affected, especially in higher
glucose conditions (tendency for IRS-1 expression to decrease).
Figure 25 – The expression of IRS-1 and GLUT4 was differentially
modulated by glucose in FSDCs.
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Figure 25 (continued) Cells were plated at 2×106 cells/well in 6-well
microplates in a final volume of 6 ml of medium, at 37◦C, with 5% CO2.
Cells were cultured in IMDM medium in a final concentration of 25 mM of
glucose (white bars) and supplemented with 5 mM of glucose (black bars),
during at least 1 weak; treated with (B) or without (A) a stimulus of LPS,
during 6h. Total RNA was isolated and retrotranscribed as indicated in
experimental procedures. The mRNA levels were assessed by quantitative
real-time RT-PCR. Gene expression is indicated as genes studied/10 000
molecules of the reference gene HPRT1 (A) and mean log2 values of fold
changes (B) relatively to the control. Each value represents the mean±S.D.
from three independent experiments (one way ANOVA multiple comparison
Dunnett’s test between 25 and 30mM of glucose with corresponding control,
in Figure 25B).
6. Cytokine, chemokine and growth factor’s profile.
FSDCs were maintained in IMDM medium or incubated with 1 µg/mL of LPS
during 6h. After incubation, total RNA was isolated from cells, quantified and reverse
transcribed to cDNA, to finally perform real-time RT-PCR. The FSDCs’
cytokine/chemokine profile was determined and is represented in Table II.
FSDCs expressed a diverse range of cytokines and chemokines, at different
levels. FDSC constitutively expressed the cytokines IL-1β, IL-6, TNF-α, G-CSF and IL-
10, the chemokine CCL5, and the growth factors EGF, VEGF and PDGF, while the
cytokine IFN-γ was not expressed in these cells. The pro-inflammatory cytokines IL-1β,
IL-6 and TNF-α and the chemokine CCL5 were constitutively and largely expressed,
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while the pro-inflammatory cytokine G-CSF and the anti-inflammatory cytokine IL-10
showed a lower expression profile. With respect to GFs, FSDCs highly expressed
VEGF and PDGF, while EGF was less expressed (Table II – Ctrl).
FSDCs stimulated with LPS during 6h completely modified the expression
levels of various cytokines. Indeed, this inflammatory stimulus highly induced the
expression of the pro-inflammatory cytokines TNF-α, IL-1β, IL-6 and G-CSF, as well
as, the chemokine CCL5. The anti-inflammatory cytokine IL-10 was slightly induced.
GFs were almost unaffected by LPS (Table II – LPS).
Table II - Expression of cytokines, chemokines and growth factors in FSDCs.
Cells were plated at 2×106 cells/well in 6-well microplates in a final volume
of 6 ml of medium and treated with 1µg of LPS during 6h (LPS), or left
untreated (Ctrl), at 37◦C, with 5% CO2. Total RNA was isolated and
retrotranscribed as indicated in experimental procedures. The mRNA levels
were assessed by quantitative real-time RT-PCR. Gene expression is
indicated as genes studied/10 000 molecules of the reference gene HPRT1
(left column) or mean log2 values of fold changes (right column) relatively
to the control, as indicated in Table II. Values from the right column
represent the mean±S.D. from at least three independent experiments (**p <
0.01; ***p < 0.001 unpaired two-tailed t-student test relatively to the
corresponding control). Legend:  IL – Interleukin; TNF – Tumor necrosis
factor; G-CSF – Granulocyte-colony stimulating factor; EGF – Epidermal
growth factor; VEGF – Vascular endothelial growth factor; PDGF– Platelet-
derived growth factor.
Gene Ctrl(Genes studied/10 000 HPRT1)
LPS
(Mean log2 values of fold changes
relatively to the control)
IL-1β 1099.55 4.94 ± 3.18 (***p< 0.001, n=14)
IL-6 663.33 8.00 ± 3.22 (***p< 0.001, n=17)
TNF-α 6131.69 3.58 ± 1.17 (***p< 0.001, n=16)
IFN-γ 0.07 0.72 ± 1.34 (n=4)
G-CSF 60.81 6.65 ± 3.13 (**p < 0.01, n=5)
CCL5 4069.67 7.52 ± 2.44 (***p< 0.001, n=16)
IL-10 115.50 2.28 ± 2.29 (***p< 0.001, n=17)
EGF 14.16 -0.35 ± 1.26 (n=16)
VEGF 2229.72 -0.15 ± 1.38 (n=16)
PDGF 2100.44 0.73 ± 0.74 (**p < 0.01, n=10)
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7. Modulation of FSDCs’ cytokine and chemokine profile by neurotensin
FSDCs were subjected to different NT and LPS incubation protocols, namely:
incubation with 10 or 100 nM of NT for 6h or 30h; incubation with LPS or
simultaneously with 10 or 100 nM of NT for 6h; and incubation with 10 or 100 nM of
NT 24h before an additional stimulus of LPS for 6h; with LPS alone during 6h. After
these incubation periods, total RNA was isolated from cells, quantified and reverse
transcribed to cDNA, to finally perform real-time RT-PCR.
NT altered the expression of different cytokines in an opposite dose-related
manner, both at short and long-time periods. FSDCs incubated with 10 nM of NT for
short-time periods (6h), tended to diminish the expression of the majority of the
cytokines, namely IL-6, TNF-α and IL-10 by -0.34 ± 0.26 (n=3), -1.10 ± 0.62 (*p<0.05,
n=3) and -1.77 ± 0.91 (*p<0.05, n=3) fold, while IL-1β expression was slightly
increased by 0.42 ± 0.57 (n=4) fold, relatively to the control (Figure 26A). Incubation of
FSDCs with NT during long-time periods (30h) exerted similar effects but at a less
degree. In addition, the slight IL-1β increase in expression observed with NT after 6h of
incubation, diminished after 30h of incubation by -0.19 ± 0.46 (n=4) fold relatively to
the control. However, the chemokine CCL5 presented a significant increase of 0.74 ±
0.50 (*p<0.05, n=4) fold relatively to the control, after 30h of NT incubation,
demonstrating a slower activation in the expression of this chemokine, as it only
increased after 30h of NT incubation (Figure 26B). Controversially, the effects
produced by 10 nM of NT, were opposite to the effects observed with 100 nM of NT in
these cells. Indeed, 100 nM of NT tended to increase the expression of IL-6, TNF-α and
IL-10 by 0.53 ± 0.83 (n=3), 0.35 ± 0.26 (n=3) and 1.00 ± 0.28 (n=3) fold and decrease
IL-1β expression by -0.37 ± 0.39 (n=3) fold, relatively to the control and during the
short-time incubation period of 6h (Figure 26A); during the long-time incubation period
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of 30h, the tendency to increase was clearly diminished and occurred an increase of IL-
1β expression by 0.56 ± 0.69 (n=5) fold, relatively to the control (in contrast to 6h of
incubation) (Figure 26B). In conclusion, 10 nM of NT significantly decreased the
expression of crucial inflammatory mediators, such as TNF-α and IL-10 at 6h and
augmented the expression of the chemokine CCL5 at 30h; 100 nM of NT induced the
opposite response, although without significance.
NT altered the expression of different cytokines, in LPS-stimulated FSDCs, both
at short and long-time incubation periods. When cells were simultaneously incubated
with LPS and 10 nM of NT during 6h, the cytokine profile was identical to the profile
induced by the NT stimulus alone. There was a tendency to decrease IL-6 and TNF-α
expression by -0.57 ± 1.21 (n=4) and -0.97 ± 0.89 (n=3) fold and a tendency to an
earlier (after 6h of LPS and NT incubation relatively to the increased expression of
CCL5 only observed after 30h of NT incubation) CCL5 increase by 0.54 ± 1.37 (n=3)
fold, relatively to the control; IL-1β and IL-10 expression was unaltered (Figure 27A).
Furthermore, when cells were pre-treated with 10 nM of NT during 24h and then
incubated with LPS for 6h, the cytokine profile appeared to completely change. There
was an upregulation of the expression of all cytokines, with a significant increase of IL-
1β expression by 1.18 ± 0.42 (***p < 0.001, n=4) and a clear tendency in the
upregulation of IL-6 expression by 0.70 ± 1.66 (n=6), relatively to the control (Figure
27B). Pre-treatment (24h) of FSDCs with NT concentrations simulated an in vivo and
artificial treatment with NT immediately after skin injury (before the start of
inflammation). Simultaneous cell treatment with LPS and NT (6h) simulated a
treatment with NT after injury where the inflammation had already started. In
inflammatory conditions, this situation may be represented by the release of NT by skin
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Figure 26 – The expression of cytokines and chemokines was
differentially modulated by NT (10 and 100 nM), after 6 and 30h of
incubation, in FSDCs.
FSDCs were plated at 2×106 cells/well in 6-well microplates in a final
volume of 6 ml of medium and treated with 10 nM (white bars) and 100 nM
(black bars) of NT, during 6h (A) and 30h (B), at 37◦C, with 5% CO2. Total
RNA was isolated and retrotranscribed as indicated in experimental
procedures. The mRNA levels were assessed by quantitative real-time RT-
PCR. Gene expression is indicated as mean log2 values of fold changes
relatively to the control. Each value represents the mean±S.D. from at least
three independent experiments (*p < 0.05 one way ANOVA multiple
comparison Dunnett’s test between 10 and 100 nM of NT stimuli with
corresponding control).
BA
B
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Figure 27 – The expression of cytokines and chemokine was
differentially modulated by LPS (1µg) and NT (10 and 100 nM), after 6
and 30h of incubation, in FSDCs.
FSDCs were plated at 2×106 cells/well in 6-well microplates in a final
volume of 6 ml of medium and treated with 1µg of LPS and 10 nM (white
bars) and 100 nM (black bars) of NT, during 6h (A) and 30h (B), at 37◦C,
with 5% CO2. Total RNA was isolated and retrotranscribed as indicated in
experimental procedures. The mRNA levels were assessed by Quantitative
real-time RT-PCR. Gene expression is indicated as mean log2 values of fold
changes relatively to LPS. Each value represents the mean±S.D. from at
least three independent experiments (***p < 0.001one way ANOVA
multiple comparison Dunnett’s test between 10 and 100 nM of NT stimuli
with corresponding control).
A
B
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B
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cells or nerves. Indeed, this pre-treatment adjusted cytokine profile to a more pro-
inflammatory output. Cells treated with 100 nM of NT did not evoke the same response
as did 10 nM of NT after 6h. Although the expression of TNF-α remained similar to that
of 10 nM of NT, the expression of IL-6 showed a tendency to increase, while CCL5 to
diminish (Figure 27A). At long-time incubation periods of these cells with both 10 and
100 nM of NT, the expression of cytokines and CCL5 was upregulated (Figure 27B).
8. Modulation of the growth factor’s profile by neurotensin
FSDCs were incubated with 10 or 100 nM of NT, 1 µg/mL of LPS or LPS and
10 or 100 nM of NT during different time incubation periods: incubation with 10 or 100
nM of NT for 6 or 30h; incubation with LPS or simultaneously with 10 or 100 nM of
NT for 6h; incubation with 10 or 100 nM of NT 24h before an additional stimulus of
LPS for 6h; incubation with LPS alone during 6h. After these incubation periods, total
RNA was isolated from cells, quantified and reverse transcribed to cDNA, to finally
perform real-time RT-PCR.
As seen previously, FSDCs constitutively expressed lower levels of EGF and
higher levels of VEGF. FSDCs stimulated with 10 nM of NT decreased EGF expression
when incubated at short-time periods while its expression was increased after 30h of NT
incubation; while the expression of VEGF tended to diminish after 6 and 30h of
incubation (Figure 28A). When FSDCs were simultaneously treated with NT and LPS,
EGF expression tended to be increased at both incubation periods, although VEGF
expression was almost unaltered (Figure 28B).
In FSDCs stimulated with 100 nM of NT the results had opposite tendencies at
6h of NT incubation – increased EGF and VEGF expression – while no differences
were detected in long-time incubation periods (Figure 28A). In FSDCs stimulated with
LPS and 100 nM of NT, EGF and VEGF expression did not vary to a large extent, only
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VEGF expression had a slight tendency to decrease (Figure 28B). In summary, the
results demonstrated that NT increased EGF levels, while VEGF levels decreased, in
these conditions.
Figure 28 – The expression of the growth factors was differentially
modulated by NT and LPS in FSDCs. Cells were plated at 2×106 cells/well
in 6-well microplates in a final volume of 6 ml of medium and treated with
10 nM (white bars) or 100 nM (black bars) of NT (A) and treated with 1µg
of LPS and 10 or 100 nM of NT (B), during 6 or 30h, at 37◦C, with 5% CO2.
Total RNA was isolated and retrotranscribed as indicated in experimental
procedures. The mRNA levels were assessed by quantitative real-time PCR.
Gene expression is indicated as mean log2 values of fold changes relatively
to the control. Each value represents the mean±S.D. from at least three
independent experiments (one way ANOVA multiple comparison Dunnett’s
test between 10 and 100 nM of NT stimuli and corresponding control).
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9. FSDCs morphology
9.1. Cell morphology
FSDCs were incubated with 10, 50 and 100 nM of NT, with LPS or with LPS in
the presence of different concentrations of NT, from 1 to 7 days of incubation, to
analyze the morphology of the cells by transmission microscopy. NT (10, 50 and 100
nM) did not change FSDCs morphology, either in the presence or in the absence of LPS
during the 7 days, as observed in Figure 29. However, LPS alone or in the presence of
NT, provoked morphologic alterations in the cells at day 7, as evidenced by the
heterogeneity of the cells, characterized by irregular morphology with rounded and
fusiform cells.
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Figure 29 – FSDCs morphology.
FSDCs were maintained in IMDM medium (control), or were incubated with
1 µg/ml of LPS, or with LPS in the presence of 10, 50 or 100 nM of NT,
during 7 days. The images were acquired by transmission microscopy and
photographs were taken with 200X magnification.
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9.2. Cytoskeleton and nuclei morphology
FSDCs were incubated with either 10 or 100 nM of NT, 1 µg/mL of LPS, or
LPS and NT (10 or 100 nM), during 24h. FSDCs morphology was analyzed by
fluorescence microscopy, in order to evaluate actin and nuclei staining (Figure 30). In
control conditions, FSDCs had actin arrangements dispersed through the entire cell, but
with sutured actin filaments in the periphery of the cytoplasm, evidencing numerous
vesicles related to the high endocytic activity of these immature cells. Some cells also
had dendritic-like projections (Figure 30, E-G). When cells were stimulated with LPS or
NT, the actin in the periphery of the cytoplasm was more sutured in some regions than
in others and the actin cortical network appeared to be disassembly, probably
demonstrating FSDCs adjustments for migration. Some dendritic-like projections were
also seen in LPS or NT stimulated cells (Figure 30, H-J). Generally, the nuclei of
FSDCs in control conditions showed normal morphology (Figure 30 – A and B).
However, in some cases, the chromatin appeared condensed and the DNA and nuclei
fragmented (Figure 30 – C and D), revealing a programmed cell death (apoptosis). In
inflammatory conditions, this apoptotic nuclei morphology was enhanced.
Figure 30 – FDSC cytoskeleton and nuclei morphology.
BA C D
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Figure 30 (continued) FSDCs were imunostained with Alexa Fluor 555
phalloidin (red) antibody for actin and stained with DAPI (blue) for the
nuclei. Images A to D show nuclear morphology; E, F and G represent
FSDCs in normal conditions; H, I and J are representative of LPS or LPS
and NT stimulated cells. Immunostaining was performed as described in
“Material and Methods”. The images were acquired by fluorescence
microscopy and photographs were taken with 400X magnification.
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10. Summary
Table III –The effect of neurotensin on FSDCs
10 nM of NT 100 nM of NT LPS + 10 nM of NT LPS + 100 nM of NT
Time
incubations
Short-time
incubation
Long-time
incubation
Short-time
incubation
Long-time
incubation
Short-time
incubation
Long-time
incubation/ NT
pre-treatment
Short-time
incubation
Long-time
incubation/ NT
pre-treatment
Viability = 1st ↑ 2nd ↓ = ↓1st ↓2nd ↑ = ↓ = ↑
Nitrite
production ___N/A
↓Day 1 and 3
↑Day 7 ___N/A
↓Day 1 and 3
↑Day 7* ___N/A
↑Day 1
↓Day3,5,7 ___N/A
↑Day 1,3,5,7
Signaling ↑Akt, p38↓NF-B ___N/A
↑Akt, p38
↓NF-B ___N/A
↑p38, ERK
↓JNK, NF-B ___N/A
↑p38, ERK
↓JNK, NF-B ___N/A
Cytokines
↓IL-6, TNF-
α*, IL-10*
↑IL-1β
↓ TNF-α , IL-
1β
↑ CCL5
↑IL-6, TNF-α,
IL-10
↓ IL-1β
↑IL-10, IL-1β,
TNF-α*
↓IL-6, TNF-α
↑CCL5
↑IL-1β*, IL-6,
CCL5
↓TNF-α,
CCL5
↑IL-6
↑TNF-α,
CCL5
Growth
Factors ↓EGF, VEGF ↑EGF ↑EGF, VEGF = ↑EGF ↓EGF, VEGF = =
Time incubations: Short-time incubations: Viability, Nitrite production and signaling: 5-60min; Cytokines and Growth Factors: 6h
Long-time incubations: Viability, Nitrite production: 1-7days; Cytokines and Growth Factors: 30h
Legend: =No alteration observed;  ___N/A – Not available; ↑Upregulation; ↓Downregulation;
IL – Interleukin; TNF – Tumor necrosis factor; EGF – Epidermal growth factor; VEGF – Vascular endothelial growth factor
Statistical differences: p < 0.05
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Table IV – The effect of LPS on FSDCs
Control LPS
Viability = ↓
Nitrite = ↑
Signaling = ↑NF-B, JNK, ERK, p38
Cytokines, Chemokines and GFs IL-1β, IL-6, TNF-α, G-CSF, IL-10,CCL5, EGF, VEGF and PDGF.
↑TNF-α, IL-1β, IL-6, G-CSF,
CCL5 and IL-10
NT = ↑***
NTRs ↑NTR1, NTR3* ↓NTRs (NTR2*)
IRS-1 +25 mM +30 mM +25 mM +30 mM
GLUT4 +25 mM +30 mM +25 mM +30 mM
Morphology =
Heterogeneity:
1)↑size, rounded
2) Thin,  directional dendrite-like
projections
Legend: =No alteration observed; ↑Upregulation; ↓Downregulation
IL – Interleukin; NTR – Neurotensin receptor; GLUT4 – Glucose transporter 4; IRS-1 – Insulin receptor
substrate-1
Statistical differences: *p < 0.05; ***p < 0.001
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1. Neurotensin and neurotensin receptors
NTR1, NTR2 and NTR3 were all expressed in BJ cells, whereas the NTR2 was
the most abundant (Figure 31A), as determined by real-time RT-PCR analysis. An
inflammatory stimulus of LPS during 6h on BJ cells revealed an increased expression
Figure 31 – Expression of NTRs (NTR1, NTR2 and NTR3) in BJ cells.
Cells were plated at 8×105 cells/dish in 60mm dishes in a final volume of
6ml of medium, at 37◦C, with 5% CO2. Total RNA was isolated and
retrotranscribed as indicated in experimental procedures. The mRNA levels
were assessed by quantitative real-time RT-PCR. Gene expression is
indicated as genes studied/10 000 molecules of the reference gene HPRT1
(A) and mean log2 values of fold changes (B) relatively to the control. Each
value represents the mean±S.D. from three independent experiments (*p <
0.05 unpaired two-tailed t-student test in Figure 31B).
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of the NTR1 by 2.9 ± 1.9 (*p < 0.05, n=3) and 0.7 ± 0.9 (n=3) fold, relatively to the
control, while the expression of NTR3 slightly diminished -0.2 ± 0.3 (n=3) fold
relatively to the control (Figure 31B). NT was not constitutively expressed in BJ cells,
although barely expressed when BJ cells were stimulated with LPS during 6h (data not
shown).
2. The effect of glucose and LPS on BJ cells
To determine if high glucose levels disturbed insulin signals and GLUT4
trafficking in BJ cells, cells were cultured in DMEM medium with 30 mM of glucose to
reproduce the hyperglycemic conditions observed in diabetic patients and with lower
concentrations of glucose (25 mM). Additionally, the response of BJ cells to different
glucose concentrations was analyzed in an inflammatory environment, by stimulating
the cells with LPS for 6h.
The expression of IRS-1 and GLUT4 was studied in BJ cells cultured with 25 or
30 mM of glucose. Similar to FSDCs, BJ cells expressed both IRS-1 and GLUT4, but to
a large extent than FSDCs. In addition, cells cultured at higher glucose levels (30 mM)
tended to induce higher IRS-1 and GLUT4 expression per reference gene, by 4.27x106
± 4.09x105 and 5.66x103 ± 3.3 x103 (n=3) relatively to cells cultured at 25 mM of
glucose with the expression values per reference gene of 2.44x103 ± 1.46x103 and 7.79 ±
4.07 (n=3) (Figure 32A). This increase was also observed in FSDCs. The expression of
IRS-1 and GLUT4 was also analyzed at 25 or 30 mM of glucose in inflammatory
conditions (6h of LPS). BJ cells cultured in 25 mM of glucose showed a decrease of -
0.28 ± 0.40 (n=3) fold in IRS-1 expression and an increase of 0.64 ± 0.14 (n=3) fold in
GLUT4 expression, relatively to the control. In contrast, when cells were cultured with
30 mM of glucose, both IRS-1 and GLUT4 expression increased by 1.28 ± 0.86 and
1.59 ± 1.15 fold, relatively to the control (an event not observed for IRS-1 expression in
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FSDCs) (Figure 32B). Indeed, glucose and LPS modulated IRS-1 and GLUT4
expression in BJ cells: LPS and glucose increased the expression of these genes, not
only in normal but also in inflammatory conditions.
Figure 32- The expression of IRS-1 and GLUT4 was differentially
modulated by glucose and LPS, in BJ cells.
Cells were cultured in IMDM medium in a final concentration of 25 mM of
glucose (white bars) and supplemented with 5 mM of glucose (black bars) of
glucose, during at least 1 weak; with (B) or without (A) a stimulus of LPS
during 6h. Cells were plated at 8×105 cells/dish in 60mm dishes in a final
volume of 6ml of medium, at 37◦C, with 5% CO2. Total RNA was isolated
and retrotranscribed as indicated in experimental procedures. The mRNA
levels were assessed by quantitative real-ime RT-PCR. Gene expression is
indicated as genes studied/10 000 molecules of the reference gene HPRT1
(A) and mean log2 values of fold changes (B), relatively to the control. Each
value represents the mean±S.D. from three independent experiments (one
way ANOVA multiple comparison Dunnett’s test between 25 and 30 mM of
glucose with corresponding control, in Figure 32B).
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3. Cytokine, chemokine and growth factor’s profile.
BJ cells were maintained in DMEM medium or incubated with 1 µg/mL of LPS
during 6h. After incubation, total RNA was isolated from cells, quantified and reverse
transcribed to cDNA, to finally perform real-time PCR.
Non-stimulated BJ cells expressed abundantly various chemokines, like CCL5,
CCL11 and IL-8, while CCL4 was only slightly expressed. The cytokines IL-1β and IL-
6 were also expressed by BJ cells, being IL-6 the most abundant. EGF was also highly
expressed. When stimulated with LPS, the expression levels of all genes were
upregulated and the chemokine CCL4 started to be expressed in large amounts, by 8.14
± 0.53 (***p< 0.001, n=6) fold, relatively to the control (Table V).
Table V – Expression of cytokines, chemokines and growth factors in BJ
cells.
Gene Ctrl(Genes studied/10 000 HPRT1)
LPS
(Mean log2 values of fold changes)
CCL4 6.44 8.14 ± 0.53 (***p< 0.001, n=6)
CCL5 4427.68 6.23 ± 0.88 (***p< 0.001, n=4)
CCL11 25317.38 4.42 ± 0.16 (***p< 0.001, n=3)
IL-8 27505.50 5.84 ± 0.97 (***p< 0.001, n=5)
IL-1β 262.44 6.02 ± 0,66 (***p< 0.001, n=5)
IL-6 15834.42 6.08 ± 0,54 (***p< 0.001, n=5)
EGF 1007.31 2.13 ± 0.42 (***p< 0.001, n=3)
Cells were plated at 8×105 cells/dish in 60mm dishes in a final volume of 6
ml of medium and treated with 1µg of LPS during 6h (LPS), or left untreated
(Ctrl), at 37◦C, with 5% CO2. Total RNA was isolated and retrotranscribed
as indicated in experimental procedures. The mRNA levels were assessed by
quantitative real-time RT-PCR. Gene expression is indicated as Genes
studied/10 000 molecules of the reference gene HPRT1 (left column) or
mean log2 values of fold changes (right column), relatively to the control, as
indicated in Table V. Values from right column represent the mean±S.D.
from at least three independent experiments (***p< 0.001 unpaired two-
tailed t-student test with corresponding contro). Legend: IL – Interleukin;
EGF – Epidermal growth factor.
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4. Modulation of cytokine, chemokine and growth factor’s profile by neurotensin
Cells were incubated with 10 or 100 nM of NT during 30h; 1 µg/mL of LPS
during 6h; and pre-treated with 10 or 100 nM of NT during 24h before an additional
stimulus of LPS during 6h. After incubation, total RNA was isolated from cells,
quantified and reverse transcribed to cDNA, to finally perform real-time RT-PCR.
NT (10 nM) tended to decrease the expression of the chemokines CCL4 and
CCL11 by -0.31 ± 0.41 and -0.66 ± 0.35 (n=3) fold, while increase the expression of IL-
8 by 0.88 ± 0.28 (n=3) fold, relatively to the control. The cytokines IL1-β and IL-6
tended to augment by 0.83 ± 0.54 and 0.53 ± 0.35 (n=3) fold and EGF expression
significantly increased 1.07 ± 0.45 (*p<0.05, n=3) fold, relatively to the control.
Moreover, 100 nM of NT induced a similar cytokine and chemokine profile in BJ cells,
although the chemokines CCL5 and IL-8 tended to decrease, potentially inducing a
smaller inflammatory behavior in these cells (Figure 33A). All the results shown were
referenced to 30h of NT. As the cytokine/chemokine response of FSDCs to NT during
6h was more prominent than that at 30h, perhaps, BJ cells incubation with NT during 6h
would give even more pronounced responses. When cells were pre-treated with NT
during 24h and then stimulated with LPS for 6h, the behavior of these cells was
different. NT at 10 nM essentially decreased chemokines expression, namely CCL4,
CCL11 and IL-8 by -0.59 ± 0.16 (*p < 0.05, n=3), -0.37 ± 0.12 (n=3) and -0.43 ± 0.10
(n=3) fold, relatively to the control. Cytokines were mostly unaltered while the
expression of EGF increased by 0.90 ± 0.01 (*p < 0.05, n=3) fold, relatively to the
control. NT at 100 nM also diminished the majority of the chemokines, namely CCL4
and IL-8, by -0.57 ± 0.19 (n=3) and -1.59 ± 1.00 (*p < 0.05, n=3) fold, while enhanced
CCL11 by 0.65 ± 0.25 (*p<0.05, n=3) fold, relatively to the control.
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Figure 33 – The expression of cytokines, chemokines and growth factors
was differentially modulated by LPS (1µg) and NT (10 and 100 nM)
after 30h of incubation in BJ cells.
Cells were plated at 8×105 cells/dish in 60mm dishes in a final volume of 6
ml of medium and treated with 10 nM (white bars) and 100 nM (black bars)
of NT during 30h (A) or pre-treated with 10 nM (white bars) and 100 nM
(black bars) of NT during 24h and stimulated with1µg of LPS during 6h (B),
at 37◦C, with 5% CO2. Total RNA was isolated and retrotranscribed as
indicated in experimental procedures. The mRNA levels were assessed by
quantitative real-time RT-PCR. Gene expression is indicated as mean log2
values of fold changes relatively to the control (A) and LPS (B). Each value
represents the mean±S.D. from three independent experiments (*p < 0.05
one way ANOVA Dunnett’s test between 10 and 100 nM of NT with
corresponding control).
A
B
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The cytokine IL1-β was also downregulated by -0.39 ± 0.41 fold, relatively to the
control. Again, EGF expression was significantly increased by 0.99 ± 0.45 (*p < 0.05,
n=3) fold, relatively to the control (Figure 33B). The expression of CCL5 was
unaffected by 10 or 100 nM of NT, as shown in Figure 33.
Recapitulating, NT essentially diminished chemokines expression, except
CCL11 which was significantly augmented when stimulated by LPS and 100 nM of NT.
The expression of cytokines was slightly enhanced by the addition of NT but
diminished when NT was added before LPS. The expression of CCL5 was not affected
by NT while EGF expression was significantly enhanced.
5. Cytoskeleton and nuclei morphology
BJ cells were incubated with 10 or 100 nM of NT, 1µg/ml of LPS, or
simultaneously with LPS and NT (10 or 100 nM) for 24h. The morphology of BJ cells
was visualized by fluorescence microscopy, in order to evaluate actin and nuclei
staining (Figure 34). Cells were organized with actin microfilaments, displaying distinct
arrays of F-actin, namely stress fibers (green arrows in Figure 34) and fillopodia (white
arrows in Figure 34). Actin microfilaments provide forces for cellular and intracellular
movement, giving dynamic and polarization to the cells. Indeed, several BJ cells were
found with migration-like structure. In contrast to FSDCs, the nuclei of BJ cells were
not modified by NT or LPS, displaying normal and non-apoptotic nuclei. Additionally,
migrating cells displayed flattened nuclei, as shown in Figure 34D.
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Figure 34 - Actin arrangements in BJ cells.
BJ cells were imunostained with Alexa Fluor 555 phalloidin antibody (red)
for actin and stained with DAPI (blue) for nuclei. Immunostaining was
performed as described in “Material and Methods”. The images were
acquired by fluorescence microscopy and photographs were taken with 200X
(D-E) and 400X (A-C) magnification. Legend: Green arrows: Stress fibers;
White arrows: Fillopodia
A B
C
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Figure 34 - Actin arrangements in BJ cells (continued).
D
E
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6. Modulation of BJ cell migration by neurotensin
BJ cells were incubated with 10 or 100 nM of NT, 1µg/ml of LPS, and
simultaneously with LPS and NT (10 or 100 nM) for 24h, after making the scratch.
Before the incubation of NT and LPS, and after incubation, photographs were taken to
evaluate BJ cell migration. NT appeared to modulate BJ migration: NT (10 nM)
increased the number of migrated cells in the scratched area, in BJ cells treated or non-
treated with LPS; 100 nM of NT did not modify BJ migration in non-treated LPS cells,
although it increased cell migration in LPS treated cells. These results so far are
representative of only one experiment, but may indicate that NT can possibly modulate
BJ migration, conceivably upregulating cell migration.
Figure 35 – NT modulated BJ migration.
A scratch assay was performed as described in “Material and Methods” and
the number of migrating cells was counted in the scratched area. Results are
representative of one experiment.
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Figure 36 - Analysis of BJ cell migration by the in vitro scratch assay,
during 24h of incubation.
Cells were treated with LPS or NT (10 and 100 nM) or left untreated (Ctrl)
and a scratch assay was performed as described in “Material and Methods”.
The images were acquired by transmission microscopy and photographs
were taken before cell treatment (0h) and after 24h of LPS or NT incubation
(24h) with 200X magnification. Results are representative of one
experiment.
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7. Summary
Table VII – The effect of LPS on BJ cells
Table VI – The effect of neurotensin on BJ cells
Incubations Times 10 nM of NT 100 nM ofNT
10 nM of NT
(24h) + LPS (6h)
10 nM of NT
(24h) + LPS (6h)
Cytokines, chemokines
and growth factors
↓ CCL4,
CCL11
↑IL-8,IL-1β,
IL-6,EGF*
↓ CCL4,
CCL5,
CCL11
↑IL-1β, EGF
↓CCL4*,
CCL11, IL-8
↑EGF*
↓CCL4, IL-8*,
IL-1β, IL-6*
↑CCL11*, EGF*
Cell Migration ↑ = ↑ ↑
Time incubations: Cytokines, chemokines and growth factors: 30h;  Cell Migration: 24h
Legend: =No alteration observed; ↑Upregulation; ↓Downregulation; IL – Interleukin, EGF –
Epidermal growth factor
Statistical differences: *p < 0.05
Control LPS
Viability = =
Cytokines, chemokines and
growth factors
CCL4, CCL5, CCL11, IL-8,
IL-1β, IL-6, EGF
↑CCL4, CCL5, CCL11, IL-8,
IL-1β, IL-6, EGF
NT Not expressed Not expressed
NTRs NTR1, NTR2, NTR3 ↑NTRs (NTR1* and NTR3)
IRS-1 +25 mM ++30 mM -25 mM ++30 mM
GLUT4 +25 mM ++30 mM +25 mM +30 mM
Morphology With stress fibers and fillopodia
Legend: =No alteration observed; ↑Upregulation; ↓Downregulation; NTR – Neurotensin
receptor, IRS-1 – Insulin receptor substrate 1, GLUT4 – Glucose Transporter 4,  IL –
Interleukin, EGF – Epidermal growth factor
Statistical differences: *p < 0.05
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The main focus of this work was to evaluate the role of NT in the expression of
inflammatory markers by FSDCs or BJ cells, as well as, its potential repercussions in
different phases of WH. Changes in NT levels can be associated with pathological
conditions, like diabetic wound healing, and this effect will also be discussed.
The results demonstrated that NT (10 nM) downregulated the immune function
of FSDCs in homeostasis# and in vitro inflammatory* (induced by LPS) conditions.
Indeed, NT decreased nitrite production, reduced the activation of the inflammatory
signaling pathways NF-kB#* and JNK*, and reduced the expression of pro-
inflammatory cytokines#*. NT also induced the expression of the promoter of the last
phases of WH – EGF#* – and the activation of the survival signaling pathway ERK*. On
the other hand, NT also modulated chemokines expression, inducing the leukocyte
chemoattractant mediator – CCL5#*, and diminished the expression of the vascular
hyperpermeability and angiogenic inducer – VEGF#. In contrast to 10 nM of NT cell
treatment, that appears to signal through NTR1 binding, higher doses of NT (100 nM)
that seem to bind to NTR2 and NTR3, upregulated the previous pro-inflammatory
cytokines. This NT pro-inflammatory profile was also observed when cells were pre-
reated with NT and stimulated with LPS. It can be speculated that this in vitro effect
mimics a WH treatment with NT, in inflammatory conditions.
NT (10 or 100 nM) binding to NTR1, NTR2 or NTR3 diminished the expression
of pro-inflammatory cytokines and chemokines in BJ cells, induced the expression of
EGF*# and CCL11#, and finally, promoted BJ cell migration. Following, these results
will be discussed.
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1. The effect of LPS and NT on FSDCs viability
The MTT assay was used to determine if NT provoked toxicity to FSDCs, in
either short or long-time periods of incubation. As dehydrogenases activity remained
similar after NT exposures, and their activity is proportional to mitochondria activity
and therefore to the number of viable cells, it can be considered that no significant
changes in cell viability was observed in cells treated with NT. This result was
concordant with unchanged cell morphology, revealing their normal morphologic
characteristics through 7days of NT incubation, as well as, concordant with unaltered
nuclei morphology. However, some cells displayed chromatin condensation, as well as,
nuclei and DNA fragmentation, representative of cell death – apoptosis. Furthermore,
when cells were stimulated with LPS, more cells displayed apoptotic nuclei after 24h of
LPS incubation, as well as, altered cell morphology after seven days of LPS incubation.
Accordingly, inflammation signals cell death if cells cannot respond efficiently to
inflammation, which might have occurred for some cells population. Observing BJ
cells, these rarely presented apoptotic nucleus, evidencing that LPS may not activate
death receptors nor induce mitochondrial dysfunction in these cells.
The MTT assay gives information about the cells metabolism, since cells more
viable/active consume more ATP, which enhances mitochondrial and dehydrogenases
activity. Although with no statistical difference, 10 nM seemed to augment cell viability
on the first day of NT incubation, 50nM of NT on the third day, and 100 nM of NT on
the fifth and seventh days. Indeed, it appears that 10 nM NT was sufficient to increase
cell metabolism in the first day, although in long NT treatments (during 7days), which
mimics the period of WH resolution, large amounts of NT might be needed to maintain
NT effects.
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2. Cell and cytoskeleton morphology
2.1. FSDCs and cell maturation
FSDCs presented a rounded but irregular cell structure in normal conditions.
Cells also comprised size heterogeneity, although bigger cells rather than smaller cells
were preferentially present in culture. The actin cytoskeleton of these cells was
essentially disposed in the periphery of the cytoplasm, displaying sutured actin
filaments and evidencing numerous coated pits and vesicles, responsible for a high
endocytic uptake capacity of these immature non-stimulated cells. Some cells also had
dendritic-like projections. After stimulation with LPS, cells underwent morphologic
changes, increasing their size and becoming rounded, or becoming fusiform and
displaying a migratory morphology. This morphology is concordant with DCs
maturation, which is characterized by the loss of the endocytic capacity and the
acquisition of migratory properties. In addition, some cells appeared to have the actin
cortical network disassembly, probably demonstrating cytoskeleton adjustment for
migration, by losing the actin organization needed for endocytosis. Additionally, the
peripheral actin in the cytoplasm was more sutured in some regions than in others,
showing the arrangement of coated pits and vesicles in specific points, probably due to
cell interaction with LPS plus subsequent endocytosis.
2.2. BJ cells and its migratory capacity
BJ cells displayed huge actin microfilaments in all their structure. Cytoskeleton
organization gives shape and size to cells, as well as, distributes organelles inside of the
cell, contributing for their size and shape. Additionally, cytoskeleton arrangement gives
important information about significant cell functions, like cell cycle, transcription,
migration and others. Besides normal actin filaments arrangements that BJ cells
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possessed, they also displayed different arrays of F-actin, stress fibers and fillopodia.
This arrangement is characteristic of migrating FBs, as cells need to adjust their
cytoskeleton and induce forces for cellular and intracellular movement, giving
dynamism and polarization to the cells. BJ migration was observed in cells treated or
non-treated with LPS or NT. Taking this knowledge in consideration, the effect of NT
in the migratory capacity of BJ cells was studied and, in fact, their migratory capacity
was enhanced after cell treatment with 10 and 100 nM of NT. FBs migration is crucial
in the proliferation and remodeling phases of WH, as FBs migrate to the injured site and
induce fibrosis, producing ECM proteins which are important in the structure of new
granulation tissue. Indeed, NT may be involved in FBs migration in WH, when NT is
released in the skin by skin cells or nerve fibers.
3. Modulation of neurotensin receptors by LPS and low/high NT doses in FSDCs
The current data showed an altered immune response of FSDCs after treatment
with 10 or 100 nM of NT. While 10 nM appeared to promote a decrease in FSDCs
immune function, 100 nM of NT appeared to slightly activate FSDCs-mediated
production of pro-inflammatory cytokines.
3.1. Expression of NTRs under control and inflammatory conditions
FSDCs expressed both NTR1 and NTR3 receptors, being NTR3 expressed at a
large extent, as shown in Figure 13. NTR1 and NTR3 gene expression was concordant
with NTRs protein levels. In addition, NT signaling in FSDCs occurred through NTR1,
as the signaling pathways modulated by NT, after NTR1 inhibition by the selective
antagonist SR48692, returned to normal (Figures 20 to 24).
The expression of NTRs with low (10 nM) and high (100 nM) doses of NT has
been controversial. With high doses of NT, some studies infer that NT exerts a chronic
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negative regulation on NTR1 expression (Azzi et al., 1996), while others infer that high
doses of NT promote NTR1 gene activation (Najimi et al., 1998). Considering the cell
treatment with low doses of NT, the literature is concordant and states that NT induces
NTRs expression, as this is the only source of NTRs reposition into cell membranes,
even though, with limiting number of de novo synthesized receptors (post-transcription
mRNA destabilization) (Najimi et al., 1998). The present data showed that low doses of
NT during 6h increased NTR3 expression, in accordance with the literature. The
expression of NTRs with high doses of NT was not determined in this work.
NTRs expression declined in LPS-stimulated cells (Figure 14) probably
explaining the non-prominent NT effects observed in these studies. Furthermore, these
results demonstrate that NT levels and consequent effects are downregulated in FSDCs,
under inflammatory conditions.
3.2. Endogenous NT expression
In inflammatory conditions, endogenous NT expression was augmented in
FSDCs, although these elevated NT levels would not act on FSDCs, as NTRs were
downregulated by inflammatory conditions (Figure 14). Furthermore, dendritic cells
expressed this neuropeptide, which may be released and further exert its effects in other
surrounding skin cells, like KCs, FBs, and others. Additionally, in inflammatory
conditions, the downregulation of NTRs might be important to suppress the effects of
high NT concentrations that are pro-inflammatory (discussed further in detail). In fact,
some pathologies are characterized by the upregulation of NTRs expression which
induce an excessive pro-inflammatory environment (Castagliuolo et al., 1999; Wang et
al., 2000). Concluding, 10nM of NT induced an anti-inflammatory character in FSDCs,
under normal or inflammatory conditions.
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Although the increase of endogenous NT expression guided us to its importance
in these cells, this augment may omit the effect of the external NT added to the cells in
inflammatory conditions.
3.3. NTRs sensitization
In accordance to the literature and previous results, NTRs expression is
augmented with low doses of NT and might be diminished or augmented with high
doses of NT exposures. At low doses of NT, the expression of NTRs is effectively
important, as this is the only source of receptors replacement in the cell surface, in
contrast to high doses of NT. Indeed, at low doses of NT, NTR1 is targeted to
lysossomal degradation after NT-NTR1 binding, however, at high doses of NT, NTR1
is targeted to other compartment (juxta-nuclear compartment identified as the Trans
Golgi Network/PNRC) being recycled to the membrane, without the agonist (Sorrell J.
& A.I. Caplan, 2006). It is also known that NTR3 is essentially located in the Trans
Golgi Network (TGN) compartment and NTR1 may form heterodimers with NTR3.
Indeed, with high doses of NT, NTRs increase at the cell surface and not only NTR1
can be recycled to the membrane, but also NTR3, while with low doses of NT, only de
novo synthesis introduces NTRs in cell membranes. In summary, low doses of NT
induce cell desensitization by NTR1 degradation and high doses of NT induce
permanent cell sensitivity to NT, probably analogous to the previous results observed
with 10 nM and 100 nM of NT. Indeed, the results observed with 10 nM of NT may
indicate that NTRs undergo the process of desensitization but increase the expression of
NTRs (later) that contradicts the decrease of NTRs in the cell membrane after
internalization. Independently of NTRs expression, results with 100 nM of NT may
show that FSDCs undergo the process of NTRs sensitization, targeting NTR1 and
NTR3 to the cell surface and rapidly augmenting NT effects. In this work this process
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was not clarified. To clarify these results, immunocitochemistry of the NTRs at the cell
surfaces, in cells treated with low and high doses, should be performed.
3.4. Differences between the biological functions of NTR1 and NTR3
The interpretation of this dual NT character guided us to reflect about the effects
of low and high levels of NTRs at the cell surface, as well as, the possible increase of
NTR3 at the cell surface, with high doses of NT. As demonstrated in this work, FSDCs
expressed and produced both NTR1 and NTR3. However, NT signaling occurred
mainly through NTR1 (demonstrated by NTR1 inhibition, Figures 20 to 24) and
possibly because the NTR3 might be essentially inside of the cell and not present at the
cell surface. In addition, low (10 nM) NT concentrations bound to NTR1 and mediated
the inactivation of inflammatory pathways, although at high concentrations (100 nM),
NT might have caused permanent NTRs sensitization, inducing an excessive presence
of NTRs at the cell surface, namely NTR1 and NTR3. As a consequence, 100 nM of NT
may bind to NTR1 or NTR3 in an unspecific way, inducing an opposite response to 10
nM of NT, a pro-inflammatory response. This pro-inflammatory response may be
mediated by the binding of NT to NTR3 or to NTR1 and NTR3.
While all NTRs have affinity for NT binding, the consequent cell response after
NT binding to a NTR may be different. Indeed, the difference between NTR1 and
NTR3 support this affirmation: NTR1 is a G protein-coupled receptor, whereas NTR3 is
an intracellular receptor with a single transmembrane domain. In addition, these
receptors have different intracellular domains which are responsible for intracellular
activation. Not only NTRs differences may alter cell response, but the activation of
GPCR and the host cell of the receptor. To illustrate the previous statements, a more
documented NT function in the nervous system and the gastrointestinal tract was
analyzed. Indeed, in the nervous system, NT has a pro-inflammatory role, inducing the
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expression of several cytokines/chemokines, including IL-1 and MIP-2 in microglia
cells, mediated by NT binding to NTR3 (Dicou et al., 2004). In a recent study
performed in the gastrointestinal tract, NT mediates an anti-inflammatory response,
characterized by the decrease of IL-6 and TNF-α (the receptor by which this response
was mediated was not clarified) (Assimakopoulos et al., 2008). In conclusion, different
receptors in different host cells mediate different molecular responses. Accordingly, 10
nM of NT may bind to NTR1 and mediate inflammation downregulation, while 100 nM
of NT may highly increase NTR1 and NTR3 at cell surfaces, where NTR3 binding may
be responsible for the opposite immune response, a pro-inflammatory response. The
effects mediated by NT binding to NTR3 could be elucidated by the inhibition of NTR3
with an antagonist. However, until the present date it was not developed an antagonist
to NTR3.
4. Modulation of neurotensin receptors by LPS and low/high doses of NT in BJ
cells
In contrast to FSDCs, as shown in the Figures 21, 23, 26 and 27 in the results, BJ
cells did not seem to mediate different NT responses when NT was added in low and
high doses. In fact, BJ cells responded to NT in a dose-dependent manner.
4.1. NTRs expression under homeostatic and inflammatory conditions
In control conditions, BJ cells highly expressed the NTR2, being the NTR3
expressed to a less extent. FSDCs highly expressed the NTR3 although FSDCs
mediated immune functions probably occurred through NTR1, as shown in Figure 12
and 13. Indeed, the same neuropeptide may bind different NT receptors, in different
cells of the same tissue, like the skin. Attending that the NTR3 is present essentially in
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the cytoplasm, it can be speculated that NT signaling and consequent immune responses
might have occurred through the NTR2.
After cell exposure to LPS, instead of observing a decrease in NTRs expression,
as it occurred in the case of FSDCs (Figure 14), LPS on the other hand induced the
expression of NTR1 and the NTR2, and a modest decrease of the NTR3 expression.
Accordingly to these results, cells do not respond equally to inflammatory conditions
and may readjust their transcription machinery in opposite ways. While FSDCs
repressed the expression of NTRs and diminished excessive NT binding, BJ cells
activated NTRs expression to augment NT effects. In addition, as BJ cells express
NTR1, NTR2 and NTR3 under inflammatory conditions, NT effects may occur through
one of the three receptors, in preference by the NTR1, as the NTR3 gene expression is
slightly decreased and the NTR2 has less affinity for NT in comparison to the other two
receptors (Chalon et al., 1996).
4.2. Expression of endogenous neurotensin
In contrast to FSDCs (Figure 13 and 14), BJ cells did not express NT and it was
barely induced by LPS. In inflammatory conditions, the expression of NTRs increased,
indicating that NT may be important for BJ cells in these conditions. Indeed, NT
produced by other cells, like FSDCs, or released by peripheral nerves in inflammatory
conditions, may bind NTRs and activate consequent signaling in BJ cells. In normal and
inflammatory conditions, NT downregulated the expression of chemokines and
upregulated the expression of EGF, reducing inflammation and possibly inducing the
last phases of WH (discussed further in this chapter).
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4.3. NTRs sensitization
FSDCs expressed NTR1 and NTR3, and even in the presence of NTR3, the
signaling occurred essentially through NTR1, at short periods of incubation. In normal
conditions, BJ cells expressed the NTR2 and the NTR3, whereas the NTR2 was highly
expressed although with low affinity for NT (Chalon et al., 1996), and NTR3 was
possibly present inside of the cell, considering the literature. With high concentrations
of NT, NT signaling through NTR3 should augment, as these receptors are targeted to
cell membrane and since this receptor has high affinity for NT. In summary, with low
and high doses of NT, the effects of NT occur through the NTR2 and the NTR3,
explaining similar biological effects, although to a further extent with high doses of NT
that signal through NTR3.
4.4. Biological functions of NTR2 and NTR3
In this case, with low and high doses of NT, signaling may occur simultaneously
through two receptors (NTR2 and NTR3) and through the three receptors (NTR1, NTR2
and NTR3) in LPS-stimulated cells, instead of one (in contrast to NT signaling in
FSDCs). As the NTR responsible for the NT effects was not confirmed by NTR
inhibition in these cells, since neither an antagonist for NTR2 or for NTR3 exists, the
function of NTR2 and NTR3 alone was not determined. Even though, NT signaling in
normal and in inflammatory conditions induced a similar outcome, decreasing immune
cells function. This similar function may be related with a similar intracellular domain
but is discondart with NTRs structure, as NTR1 and NTR2 are GPCRs, whereas NTR3
is an intracellular receptor with a single transmembrane domain. Also, this response can
also be mediated simply by the augment of NTRs at the cell surface and NT signaling.
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Table VIII – Evaluation of the NTRs signaling in FSDCs and BJ cells
surfaces.
NTRs in FSDCs NTRs in BJ cells
Low doses of NT NTR1, (NTR3) NTR2, (NTR3)
High doses of NT NTR3, NTR1 NTR2, NTR3
Inflammatory exposure NTR1, (NTR3)↓NTRs
NTR1, NTR2, (NTR3)
↑NTRs
()-Expressed but essentially existing inside of the cell; ↓↑ Diminishment/Augment of expression; NT has less
affinity for NTR2; Bold – NTR responsible for NT functions.
5. Cytokine, chemokine and growth factor’s profile
5.1. FSDCs
As seen before, 10 nM of NT decreased IL-6, TNF-α, IL-10 and PDGF
expression, while it increased the expression of CCL5 and EGF. IL-6 and TNF-α are
acute phase cytokines known to induce the first phase of inflammation in WH. IL-6 (↓)
induces C-reactive proteins, B cells stimulation to produce antibodies, influences
antigen-specific immune responses, promotes T cell growth and cytotoxic T cell
differentiation, enhances adhesion molecules in ECs, and improves leukocyte
accumulation at the site of inflammation (Jones et al., 2005). TNF-α (↓) induces
adhesion molecules and chemokines in the skin, leading to attachment of inflammatory
cells to vessels, rolling, emigration, and eventually chemotaxis into the skin (Briscoe et
al., 1992; Swerlick et al., 1992). All these functions are crucial to the onset of
inflammation in the initial phases of WH. IL-1β, an important cytokine in innate
immunity essential to kill pathogens and produce inflammatory mediators, like NO,
have their expression levels whether increased (short-time incubations) or decreased
(long-time incubations) in NT treated cells, as shown in Figure 26 and 27A. Indeed, NT
may not be responsible for the modulation of the expression of this cytokine. All the
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cytokines mentioned before are important molecules in the acute phase of inflammation,
imperative for the initial steps of WH. However, all these cytokines have their
expression levels decreased, evidencing that FSDCs may repress this phase of WH.
IL-10 (↓) is the most studied anti-inflammatory cytokine, mediating the end of
the inflammatory phase of WH (opposite to the previous cytokines). Indeed, IL-10 is
known to suppress antigen presentation by LCs, dermal DCs, MΦs and monocytes; to
repress cytokine and chemokine production, such as TNF-α, IL-1, IL-6, IL-8, IL-12
from monocytes, MΦs, eosinophils, T cells, MCs and neutrophils; to induce the
expression of MHC class II, CD86, CD54 and CD40 in monocytes and enhance MΦs
antigen presentation; to induce IL-1RA production and soluble TNF receptors in
monocytes, MΦs and neutrophils; to induce antigen-induced histamine liberation in
MCs; to promote NK cells cytotoxicity and B cells growth; and finally, to induce E-
selectin in ECs (Asadullah et al., 2003). Although FSDCs are not producers of high
amounts of IL-10, NT downregulated the modest IL-10 expression of FSDCs, as shown
in Figure 26 and 27A.
CCL5 or RANTES (↑) expression was upregulated by NT. RANTES induces
leukocyte migration by binding to specific receptors, namely CCR1, CCR3, CCR4 and
CCR5. It mediates the activation, traffic and homing of classical lymphoid cells such as
T cells and monocytes, as well as, T cells, DCs, eosinophils, NK cells, MCs and
basophils to and from the site of inflammation (Rossi D. & A. Zlotnik, 2000). After 30h
of incubation, NT increased CCL5 expression in control and inflammatory conditions.
As CCL5 is an unspecific chemokine, it can be modulated by different signaling
pathways (described later), and so, after long-time NT incubations, this unspecific
chemokine can be activated. Indeed, the immunosuppressive function of NT did not
seem to modulate this cytokine.
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Epidermal growth factor (↑) expression was increased by NT and, according to
its denomination, it induces epidermal growth. EGF-R is strongly, although not
exclusively, expressed in the basal layer of the epidermis and EGF binding to EGF-R
induces KCs proliferation, differentiation and migration, promoting epidermal thickness
(Jost et al., 2000). Furthermore, it is known that EGF treatment of the wound
accelerates wound healing (Grzybowski et al., 1999) and also that EGF is important in
the last phases of WH. Indeed, the upregulation of EGF expression by NT may promote
the migration-remodeling phases of WH.
VEGF-A (↓) was decreased by NT at short-time incubation periods. VEGF is an
important regulator of endothelial cell proliferation, migration and cell survival,
inducing vascular hyperpermeability and angiogenesis, as well as, inducing
monocyte/macrophage recruitment (Chalon et al., 1996). All these processes are
involved in the first phases of WH, to create blood vessels which are important in the
migration of APCs to lymph nodes and leukocytes to the injury site. However, in the
last phases of WH, this growth factor is no longer important and may be decreased.
Indeed, low doses of NT may repress the inflammatory phase of WH and
enhance the proliferating and remodeling phase of WH, by diminishing the expression
of cytokines and VEGF, and increasing EGF. However, high doses of NT promoted the
opposite response, a pro-inflammatory response of FSDCs that may be responsible for
the constant inflammatory state of wound healing observed in skin wound diseases.
5.1.1. Signaling pathways and cytokine, chemokine and growth factor’s profile
The association between the signaling pathways and cytokine profile will be
discussed in cells which were incubated with 10 nM of NT. The activation of signaling
pathways with 100 nM of NT was also tested and the results were very similar to those
obtained with 10 nM. As NT incubations were performed for the period of 1h, the
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observation of different signaling pathways’ activation with 100 nM of NT incubations
should conceivably be done during longer incubation periods, to permit NTRs
sensitization.
The activation of signaling pathways was determined in two different conditions,
with and without an inflammatory LPS stimulus. LPS (a component of bacteria) bound
to toll-like receptor (TLR)-4 in the cells, activate inflammatory signaling pathways, like
NF-B and MAPKs (ERK, p38 and JNK). This activation is mediated by the TLR
cytoplasmic domains resemble that of the IL-1 receptor, and hence called Toll-IL-1-
Receptor (TIR) domains. After LPS binding to TLR, dimerization occurs and TLR
recruits the adaptor protein MyD88 (Medzhitov et al., 1998) and induces consequent
downstream signaling. In accordance, the interpretation of the activation of signaling
pathways by LPS and NT interference was easily determined, while with no LPS
stimulus, the inflammatory pathways were only slightly activated and so, NT effects on
signaling were difficult to observe in these studies.
Although these pathways have a distinct inflammatory profile, inside of the cell,
the phosphorylation of a single protein involved in one signaling pathways may have
repercussions on other signaling pathways. NT downregulated the activation of
signaling pathways involved in inflammation, namely NF-B and JNK, upregulated a
signaling pathway involved in cell growth and survival – ERK – and upregulated a pro-
inflammatory pathway – p38, as shown in Figure 18 to 24. In order to establish a
connection between NT (in)activated signaling pathways and NT induced cytokine
profile, a deep literature research about the involvement of these signaling pathways and
cytokine expression was done and considered when analyzing the present data.
The activation of the signaling pathway NF-B is involved in diverse immune
responses mediated by cells, increasing genes transcription like chemokines (IL-8,
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CCL5, MIP-1 and MCP-1), cytokines (IL-6, IL-1β, TNF-α, GM-CSF, IL-4 and IL-5),
adhesion molecules (VCAM-1, ICAM-1 and E-selectin), enzymes that produce
secondary inflammatory mediators (iNOS, COX-2 and PLA2) and inhibitors of
apoptosis (Ghosh et al., 1998). Indeed, NF-B downregulation observed in FSDCs may
have caused the decrease of NO production observed in FSDCs stimulated with 10 nM
of NT in homeostatic and inflammatory conditions (Figure 17 and 21), probably by the
decrease of iNOS expression (discussed further in this chapter). Additionally, the
downregulated expression of the cytokines IL-6 and TNF-α might have been caused by
decreased NF-B activation, as the association between NF-B activation and IL-6 and
TNF-α expression was already described in our lab, in FSDCs (Neves et al., 2009). As
this signaling pathway is activated in the initiation of acute phase response and
consequently induces the expression and production of acute phase-related genes, NF-
B downregulation may diminish this phase and so, diminish the immune responses of
FSDCs.
The JNK signaling pathway is also involved in diverse inflammatory functions.
In addition to NF-B, JNK can be activated by LPS or inflammatory cytokines such as
TNF and IL-1 (Davis R.J., 2000). After activation, JNK may induce the production of
multiple cytokines, including type I interferon and IL-6 (Chu et al., 1999). JNK also
activates different transcription factors, such as c-JUN (component of the transcription
factor AP-1), ATF2 and SP-1, involved in the transcription of different cytokines.
Indeed, the inactivation of this signaling pathway can also be involved in the
downregulation of IL-6 expression. Furthermore, considering that NT downregulated
this signaling pathway (as it also occurred with NF-B), it still remains to be elucidated
how NT downregulation occurs. Accordingly to the literature, one possible way of JNK
downregulation, may involve the activation of MAPK phosphatases. MKPs may
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dephosphorylate different substrates of different signaling pathways with different
affinities. For instance, MKP-1 has great affinity for p38 and pJNK (but less for ERK)
(Tanoue et al., 2000) and MKP-5 for JNK, rather than p38 (Zhang et al., 2004), and
these phosphatases are involved in the downregulation of the cell’s immune functions,
triggered by these pathways. In accordance, MKP-1 knockout mice are involved in
enhanced innate immune responses, as this phosphatase regulates cytokine production
in MΦs and DCs. In MΦs, MKP-1 negatively regulates IL-10 and in MKP-1-deficient
DCs the levels of pro-inflammatory cytokines (including TNF-α and IL-6) and the anti-
inflammatory cytokine IL-10 increased (Dong et al., 2002; Nimah et al., 2005; Zhao et
al., 2006). In MKP-5-deficient mice, in response to various TLRs ligands, cytokines
increased and DCs displayed increased CD4+ and CD8+ Tcell priming capability
(Zhang et al., 2004). Considering the role of MKPs, and specifically the function of
MKP-1 and MKP-5 and their specificity for JNK, MKP-1 or/and MPK-5 might be
involved in JNK downregulation in FSDCs, and consequently, IL-6, TNF-α and IL-10
downregulation, presented in Figure 23 and 26A.
In contrast to the previous signaling pathways, the signaling pathway p38 is
upregulated in FSDCs (Figure 24). The signaling pathway p38 is also an inflammatory
pathway. Studies in mice deficient in the p38 kinase MKK3 showed decreased LPS-
induced IL-12 production in MΦs and p38-specific inhibitors decreased the production
of others cytokines, like TNF-α, IL-6, IL-1α and IL-1β (Lu et al., 1999; Wysk et al.,
1999). Although this signaling pathway modulate the expression of different cytokines,
in FSDCs, the upregulation of the p38 signaling pathway may be related with IL-1β
outcome, at 6h of NT exposure, while the inactivation of the others signaling pathways
(NF-B and JNK) may have a larger effect in the other cytokines (IL-6 and TNF-α),
decreasing their expression. The expression of the chemokine CCL5 increased after 30h
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of NT incubation and after 6h of LPS and NT incubation. Accordingly with the
literature, the inflammatory signaling pathways previously described induce the
expression of chemokines, like CCL5. In a focused literature research in diverse cell
types, CCL5 production is primarily induced by two signaling pathways, the NF-B and
the p38, as well as, by the Interferon regulatory factor (IRF)-8, an important factor in
IFN-δ-mediated signaling and in the development and function of DCs (Liu J. & X. Ma,
2006).  Taking this information into consideration, and largely supported by previous
results from our lab that shows that LPS-induced CCL5 expression is upregulated by
p38 (Neves et al., 2009), it can be considered that p38 phosphorylation can also be
involved in the increase of CCL5 observed in LPS stimulated and non-stimulated
FSDCs.
ERK can directly phosphorylate many transcription factors including Ets-1, c-
Jun and c-Myc, as well as, phosphorylate and activate the 90kDa ribosomal S6 kinase
(p90Rsk), which then leads to the activation of the transcription factor CREB.
Moreover, through an indirect mechanism, ERK can also lead to the activation of the
NF-B transcription factor. These transcription factors induce the expression of
important genes involved in: cell cycle progression, like Cdks and cyclins (regulated by
CREB, Ets, Ap1 and c-Myc transcription factors) and GFs, such as PDGF and heparin-
binding (HB)-EGF (regulated by the transcription factor Ets); apoptosis prevention,
such as the antiapoptotic genes Bcl-2 and p53 (regulated by CREB, Ets and AP-1
transcription factors); and cytokines, like GM-CSF, IL-2 and IL-3 (regulated by Ets and
Ap1 transcription factors) (Chang et al., 2003). Considering the NT-induced increase of
EGF expression in FSDCs, the activation of ERK may be involved in this increase.
Also, considering previous results from our lab (Neves et al., 2009), the augment of IL-
1β observed at 6h, can also be upregulated by this pathway.
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Akt is a multifunctional protein kinase involved in the regulation of multiple
cellular processes such as glucose metabolism, transcription, apoptosis, cell
proliferation, angiogenesis and cell motility (Brazil et al., 2002). Akt was slightly
activated by NT alone, although none of these functions were determined in these cells.
However, in previous results from our lab (Neves et al., 2009), Akt was involved in the
negative regulation of IL-10. Although WB results did not show an increase of Akt, in
short-time incubations of LPS with cells, probably at later times, this signaling pathway
may be activated and induce the downregulation of this cytokine.
The association between the (in)activation of signaling pathways and the
cytokine expression profile observed in this work is in accordance with previous results
performed in FSDCs and with the results from the literature. However, to confirm these
results, the signaling pathways should be inhibited with specific inhibitors before cell
stimulation with LPS and NT. Afterwards, the increase/decrease of cytokines should be
measured, determining which signaling pathways is responsible for a specific
increase/decrease on cytokines expression.
5.2. BJ cells
In agreement with the results on FSDCs, NT also decreased BJ pro-
inflammatory action, in homeostasis# and inflammatory* conditions. Indeed, 10 nM
decreased the expression of the chemokines CCL4#*, CCL11*# and IL-8*, whereas the
expression of the cytokines IL-1β, IL-6 and the chemokine IL-8 were slightly increased
only in homeostatic conditions. High doses of NT induced a major downregulated
immune profile, decreasing CCL5# and IL-8* expression, inhibiting the increase the
expression of cytokines# and even downregulating* it, and increasing the expression of
CCL11*, as shown in Figure 22.
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NT downregulated chemokines expression, namely CCL4, CCL5, CCL11 and
IL-8, that mediate immune cells recruitment to the site of inflammation (Esche et al.,
2005). Indeed, IL-8 is a neutrophil-activating cytokine, inducing chemotaxis and the
release of granule enzymes (Baggiolini et al., 1989) and CCL11 (or eotaxin) is an
important eosinophil chemoattractant which also recruits basophils, Th2 lymphocytes
and tryptase-chymase MCs (De Paulis et al., 2001; Forssmann et al., 1997; Garcia-
Zepeda et al., 1996; Sallusto et al., 1997). Being fibroblasts sentinels of inflammation
and having their chemokines expression downregulated when treated with NT,
leukocytes are not attracted to the injured skin and consequently, inflammation
decreases.
NT also promoted the expression of EGF in homeostatic and inflammatory
conditions and CCL11 expression in inflammatory conditions (Figure 22). Beyond
CCL11 chemoattractant and physiological actions, eotaxin may induce eosinophil
degranulation (Fujisaw et al., 2000) and IgE-independent degranulation of basophils
(Uguccioni et al., 1997), promoting adaptive immune responses, by the selectively
recruitment of Th2 lymphocytes, which is dependent on the expression of CCR4 and
CCR8 on Th2 (Ono et al., 2003). Indeed, the increased expression of CCL11 mediated
by NT can be implicated in a Th2 mediated response. Moreover, the enhancement of
EGF may induce an autocrine effect in BJ cells, inducing their proliferation and
differentiation, and promoting a contractile BJ phenotype, important in ECM production
and wound closure in WH. Additionally, BJ induced-EGF expression may also
modulate epidermal proliferation and differentiation, by a paracrine function in KCs.
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6. The role of NT in homeostasis, inflammatory and pathological conditions
The dual NT (10 and 100 nM) role in cells, as well as, the variation of levels and
types of NTRs expression at cell surfaces may characterize a pro- or anti-inflammatory
environment needed in tissues, in different conditions.
6.1. Low NT concentrations (10 nM of NT)
In FSDCs, low NT levels released in normal conditions modulated cell’s
immune responses, downregulating inflammation during short and long-time incubation
periods. Cells maintained in an in vitro inflammatory environment (LPS during 6h) with
a simultaneous treatment with NT may mimic the release of NT by skin cells or nerves,
in an in vivo inflammatory condition. The results obtained indicated that, in this
inflammatory state, the expression of endogenous NT in FSDCs increased although the
expression of NTRs was repressed. Indeed, what high NT levels would promote in
FSDCs – pro-inflammatory cell behavior – as NTRs expression was downregulated, not
all NT bind to NTRs and so, NT act as if its concentration was still low.
In BJ cells, NT also induced the downregulation of cell’s chemotactic function
and, consequently, their capacity to migrate, while increased EGF expression, a crucial
GF involved in cell growth and WH. In an inflammatory environment during 6h, BJ
cells still expressed NTRs and even increased their expression. Indeed, the release of
NT by nerves or expressed by surrounding cells may maximize the NT effect observed
in non-inflammatory conditions, as the NT effects are dose-dependent. Indeed,
chemokines and cytokines are significantly downregulated and the expression of EGF is
significantly increased.
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6.2. High NT concentrations (100 nM of NT)
High NT levels may occur through an alteration in cell transcription, or by an
extra NT release by the sensory nerves, which may occur under a chronic stress or
inflammation state, for instance in diabetic wound healing. In normal conditions, high
NT levels induced a pro-inflammatory character in FSDCs, determined by an increase
of pro-inflammatory cytokines and chemokines, and the production of NO. Moreover,
in inflammatory conditions, although there was slight and unclear decrease in the
expression of TNF-α and CCL5, a clear increase of IL-6 may determine a possible
promotion of FSDCs pro-inflammatory functions.
In BJ cells, high NT levels in inflammatory and non-inflammatory conditions
mediated the downregulation of chemokines and cytokines, and increased the
expression of EGF. These cells are influenced by NT in a dose-dependent manner, and
so, both with low or high NT concentrations, BJ cells respond in the same way,
decreasing their immune capacity.
6.3. The effects of neurotensin on wound healing and diabetic wound healing
In summary, low doses of NT may induce the repression of FSDCs
inflammatory action; although at high concentrations it may induce a pro-inflammatory
profile in FSDCs. Addressing FSDCs modulation by NT into WH, if low levels of NT
are released in the beginning of the inflammatory processes, NT may induce
pathological effects, diminishing the capacity of cells to respond to inflammation and
probably promoting infections; however, if low doses of NT are released in the middle
or at the end of inflammation, as well as, in the migration-remodeling phases of WH,
NT may modulate de degree of inflammation, end inflammation and induce the
progression to migration-remodeling phases of WH. Indeed, in this last case, NT acts as
a WH promoter. Concerning high doses of NT into WH, if NT is released either in
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inflammatory or migration-remodeling phases, it can activate pathological FSDCs
functions, increasing FSDCs pro-inflammatory activity, which may inhibit the
progression of inflammation to migration-remodeling phases; if released in the begging
phases, high NT levels may promote and enhance inflammation, which can be
important in the initial phases of wound healing.
Concerning BJ cells, low or high doses of NT may not be pathological if NT
exposure occurs in the middle and end of inflammation and in the migration-remodeling
phase, as in these conditions the diminishment of inflammation is needed; if NT
exposures occurs in the beginning of the inflammatory phase, as discussed earlier, the
decreased inflammation can be pathological as it may inhibit BJs sentinel function and
may promote infection.
NT is inexistent in the skin of human and rats (Seethalakshmi et al., 1997;
Pincelli et al., 1990) in homeostatic conditions, however, NT levels might increase in
inflammatory conditions or in different phases of wound healing (Figure 36). In fact,
this work still requires in vivo studies to determine when and in which amounts NT
exists in the skin.
6.4. Treatment of wound healing with NT
In vitro pre-treatment (24h) of cells with NT mimics an exogenous and previous
(to inflammation) treatment with NT. In BJ cells this pre-treatment would not evoke a
different cell response, as NTRs were not downregulated at 6h of incubation. However,
in FSDCs, as these cells have their receptors downregulated after 6h of LPS treatment,
NT treatment before inflammation (24h of pre-treatment) could promote a different
response. In these incubations, in addition to the pro-inflammatory stimulus of LPS, NT
enhanced the inflammatory response evoked by LPS, probably provoked by the
cumulative effects of LPS and NT that can be related to an increase in NTR3 at cells
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Figure 37 – Different NT concentrations promote physiological and
pathological effects in different phases of WH.
Legend: Green-Physiological effects; Red-Pathological effects; Point in
WH where [NT] (↓or↑) may act.
surfaces, inducing this pro-inflammatory state. Indeed, this pro-inflammatory profile in
FSDCs may be important in the first phases of WH. Addressing these in vitro studies to
an in vivo situation, if NT is applied immediately after injury in the wounds, previously
to the start of the inflammatory process, NT can in fact upregulate cell immune’s
function in the inflammatory phase of WH, being promissory in the treatment of normal
WH. On the other hand, if low doses of NT are applied in the wounds after injury, when
the inflammatory process had already started (in vitro cell stimulation with LPS and NT
during 6h), NT can negatively modulate the cells’ immune responses. In these
circumstances, delayed wounds known to have higher levels of NT, could possibly be
treated with antibodies for NT and decrease the NT concentration in the wounds,
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promoting WH. Moreover, once NT levels are determined in skin pathologies and if NT
is then defective, a treatment with low doses of NT may promote WH.
7. The production of NO is decreased by neurotensin, in FSDCs
In the skin, iNOS expression can be upregulated by external pathogens which
induce the production of high amounts of NO. In the human skin, NO is involved in cell
growth and cell death, in cell-cell and cell-matrix interactions and in the regulation of
inflammatory and immune responses (Bruch-Gerharz et al., 1998). Furthermore, NO is
implicated in the promotion of innate immunity required in the skin, being part of the
first barrier against external organisms. In addition, NO is an imperative upregulator of
cells’ phagocytic activity against pathogens, killing pathogens like bacteria, virus and
parasites, as well as, is involved in the increase of Th1-mediated responses. NO can be
produced by important immune cells of the skin, like LCs, and affect their function,
altering its microbicial activity, antigen presenting function and cytotoxicity (Qureshi et
al., 1996), and so, having an essential role in the immunity of the skin.
In the present studies, NT modulated NO production. Indeed, FSDCs treatment
with NT decreased the release of nitrite during 7 days, as well as, cell treatment with 10
nM of NT and LPS stimulus, also downregulated nitrite production, from 3 to 7 days, as
shown in Figure 17. Since NO is an important molecule in LCs, mediating its innate
immune response, this NO decrease implies impairment in the innate LCs functions.
The downregulation of NO is probably caused by NF-B inhibition, as NT alone or
added simultaneously with the inflammatory stimulus of LPS increased IkBα and so,
decreased NF-B activation.
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8. GLUT4 and IRS-1 expression
8.1. FSDCs
Glucose is a vital source of energy in cells, generating ATP through glycolysis
and oxidative phosphorylation. Meanwhile, inside or outside of the cells, glucose
concentration requests a balance: a smaller amount does not support cellular energy
requirements, although in greater amounts, glucose may glycosylate proteins and
transform their physiological functions. This balance starts in the regulation of external
glucose input (nutrition) and internal glucose environment (blood glucose and cellular
glucose). Moreover, glucose amount in the blood and cells is regulated through glucose
sensing cells, which determine high glucose amounts in the exterior environment and
induce their entry into the cells. β and α cells of the endocrine pancreas sense external
high glucose levels and induce the production of the hormones insulin and glucagon that
are responsible to establish glucose homeostasis. For instance, insulin and glucose can
be transported in the blood and when reaching a specific cell, insulin binds to the insulin
receptor at the cell membrane. Insulin binding leads to IRS-1 phosphorylation and
downstream signaling, important in glucose transporter trafficking to the membrane and
finally, glucose entry into the cells. High concentrations of glucose in the blood are
delivered to glucose defective cells. In this case, cells are induced by insulin to transport
the glucose transporter to the cell membrane and mediate glucose entry into cells.
Moreover, cells also have glucose sensing machinery to sense an internal defect in
glucose, similar to β and α cells of the endocrine pancreas and induce the expression of
molecules involved in insulin signaling.
Glucose-sensing in yeast is well clarified and involves two ways: one system
responds to the crucial hexokinase step of glucose utilization and the other system
involves direct binding of glucose to a “glucose-receptor”- like molecule. These systems
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activate specific protein kinases that phosphorylate transcription factors in order to
control either their activity or their cellular concentration. In mammals, β cells respond
to changes of glucose rate metabolism through GLUT2 and glukokinase (hexokinase)
that have low affinity for glucose determining blood-glucose levels (Towle et al., 2005)
and after sensing glucose alterations, induce gene transcription changes. Taking this
knowledge in reflection, it can be considered that in a surrounding hyperglycemic
environment, sensing-cells like FSDCs, readjust their metabolism. Indeed, FSDCs
treated with 30 mM of glucose, increased IRS-1 and GLUT4 expression to consent
insulin signaling and GLUT4 trafficking (Figure 25A), as expected. However, high
entry of glucose can also induce protein glycosylation which can affect their
physiological function. On the other hand, in inflammatory conditions, IRS-1
expression was diminished, while GLUT4 was slightly increased (Figure 25B). In a
LPS stimulus of 6h, several signaling pathways and gene transcription are activated
increasing energy and glucose requirements in FSDCs. After the 6h of LPS stimulus
and without changing the glucose medium, external cell glucose levels diminished in
parallel with intracellular levels. Cells should readjust and augment the expression of
the referred molecules, to prepare the cell for glucose entry, when glucose concentration
increases (as it occurs in vivo). However, this process did not occur, justifying the IRS-1
decreased expression although a slight increase of GLUT4. Without energy, FSDCs
activity might be disturbed and this might be involved in the downregulation of FSDCs’
immune function.
In this work, the insulin signaling and GLUT4 trafficking was not evaluated. For
that, glucose and insulin should be added to FSDCs followed by the determination of
IRS-1 phosphorylation levels and GLUT4 protein levels by WB analysis. These
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experiments would establish if cells adjust these proteins to different glucose and
insulin inputs.
8.2. BJ cells
BJ cells also expressed IRS-1 and GLUT4. In 30 mM of glucose, BJ cells also
increased the expression of IRS-1 and GLUT4, as it was observed in FSDCs,
evidencing a cell readjustment to high glucose concentrations. However, when cells
were stimulated with the LPS and cultured with 30 mM of glucose, instead of
diminishing IRS-1 and GLUT4 expression levels, these levels significantly increased,
indicating the physiological cell readjustment, not observed in FSDCs. Indeed, these
cells must easily adapt to glucose concentration, in contrast to FSDCs, in accordance
with Evans et al. 2003.
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Chapter VI. Conclusion

Conclusion
143
Neuropeptides have received major attention by the scientific community in the
recent years, since they are involved in the proliferation, differentiation and migration of
cells, and in immunomodulation. In the skin, both the pro-inflammatory functions of
VIP and CGRP, and the anti-inflammatory functions of α-MSH, have been previously
described in the literature. Although largely studied in diverse tissues, like the CNS and
the gastrointestinal tract, the role of neurotensin in the skin, has not been determined
until the present.
The role of neurotensin in two types of skin cells was determined, achieving the
main objectives of this work. NT essentially promoted the anti-inflammatory response
in two important cell types of the skin, the LCs, here represented by FSDCs, and FBs
represented by BJ cells. These cells are crucial in the different stages of WH: LCs play a
major role in inflammation, reaching and processing the antigen to be present to other
immune cells that return an inflammatory and immunological response; FBs are
important remodelers of the skin, not only by synthesizing MMPs that degrade the
ECM, important in the formation of the new granulation tissue, permitting angiogenesis
and cell chemotaxis to the site of inflammation, but also by producing proteins that fill
and arrange the ECM (after the degrading process of inflammation) – important in the
migration-proliferation and remodeling phase of WH. The anti-inflammatory response
of both cells to neurotensin may be significant in the closing stage of inflammation and
the synthesis of EGF and BJ migration, crucial for the initiation of the last phases of
WH.
Following this work, some future research should be done in these cell lines to
complement the obtained results. Studies should further determine the expression of
NTRs at cell surfaces (by immunocytochemistry), both at low and high doses of NT, as
well as, in inflammatory conditions. In addition, the neurotensin receptor by which NT
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signaling occurs in BJ cells should be determined, as it was not performed in this work
due to the non existence of the NTR2 and the NTR3 selective inhibitors. Considering
the modulation of NT in the synthesis of inflammatory mediators, the signaling pathway
by which this modulation occurs should also be determined by specific inhibition of the
pathways in question, namely the MAPK and Akt pathways, and the transcription factor
NF-B. In addition, to confirm the expression of the genes studied - the cytokines,
chemokines and growth factors - the effective protein levels of these genes in the cell
medium (after released by the cells) should be determined by Enzyme Linked Immuno
Sorbent Assay (ELISA). Finally, as glucose might have disturbed the transcription
machinery of FSDCs, a more directed investigation of the insulin signaling and the
GLUT4 trafficking should be performed. For that, glucose and insulin should be added
to FSDCs cells followed by the determination of IRS-1 phosphorylation levels and
GLUT4 protein levels by WB analysis. These experiments would establish if cells
adjust these proteins to different glucose and insulin inputs.
In vivo research to establish the function of NT in control and diabetic mouse
models of wound healing is already under way in our laboratory. Some of the in vivo
results obtained so far support the results presented in this dissertation. Indeed, in vivo
studies have shown that NT improves WH in control and diabetic mice, in agreement
with the effects that NT may have, as obtained in our results in vitro. Moreover, in vivo
results demonstrated that the expression of the inflammatory enzyme COX2 is increased
after wounding in control and diabetic mice, while decreased after the treatment with
NT, in accordance with the in vitro results performed for the inflammatory mediator NO
and for the expression of pro-inflammatory mediators, with low doses of NT.
Additionally, the expression of NTR1 and NTR2 was decreased in the skin of diabetic
mice, whereas NT treatment increased their expression, at day 10 in diabetic animals.
Conclusion
145
Considering the in vitro results obtained in this dissertation, NT signaling through
NTR1 in FSDCs was important in the acquisition of an anti-inflammatory profile on
these cells. NT signaling through NTR1 (higher affinity for NT than NTR2) may induce
the anti-inflammatory LCs response and, promote WH.
Finally, after knowing the role of NT in different cells and at different
concentrations, its application on skin wounds could be a potential therapy for skin
pathologies, like DFUs, a problematic and prevalent skin disease that can lead to a final
amputation. Moreover, the in vivo treatment of wounds with high doses of NT may
induce a pro-inflammatory status, promoted by LCs, which can be important in the first
phases of WH, being promissory in the treatment of normal WH. On the other hand, if
low doses of NT are applied in the wounds after injury when the inflammatory process
had already started, NT can negatively modulate the cells’ immune responses. In these
circumstances, delayed wounds known to have higher levels of NT, could possibly be
treated with antibodies for NT and decrease the NT concentration in the wounds,
promoting WH. Moreover, once NT levels are determined in skin pathologies and if NT
is then defective, a treatment with low doses of NT may promote WH.
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